var title_f23_1_23568="Management LCH in children";
var content_f23_1_23568=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F83046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F83046&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 638px\">",
"   <div class=\"ttl\">",
"    Management of multisystem Langerhans cell histiocytosis in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 618px; height: 708px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Risk organs include hematopoietic system, liver, and/or spleen.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23568=[""].join("\n");
var outline_f23_1_23568=null;
var title_f23_1_23569="Thumb spica cast 4";
var content_f23_1_23569=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80982&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Thumb spica cast: Step 4",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 330px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After placing the covered thumb through the hole in the stockinette, be sure all the material is as smooth as possible before beginning to apply the webril or other synthetic cast underpadding.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Kevin E Burroughs, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23569=[""].join("\n");
var outline_f23_1_23569=null;
var title_f23_1_23570="Patient information: Single pulmonary nodule (The Basics)";
var content_f23_1_23570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?42/11/43186\">",
"         Patient information: Breathing tests (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/34/35363\">",
"         Patient information: Lung cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/23/24946\">",
"         Patient information: Multiple pulmonary nodules (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/57/25489\">",
"         Patient information: Tuberculosis (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?32/14/32993\">",
"         Patient information: Flexible bronchoscopy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/3/1076\">",
"         Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/35/39475\">",
"         Patient information: Tuberculosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Single pulmonary nodule (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H597632370\">",
"      <span class=\"h1\">",
"       What is a single pulmonary nodule?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A pulmonary nodule, also called a lung nodule, is a &ldquo;spot&rdquo; on the lungs that is seen on a chest X-ray or CT scan. A CT scan is an imaging test that creates pictures of the inside of the body. If there is only 1 spot, it&rsquo;s called a &ldquo;single&rdquo; (or &ldquo;solitary&rdquo;) pulmonary nodule.",
"     </p>",
"     <p>",
"      A single pulmonary nodule usually causes no symptoms. People find out they have it after they have a chest X-ray or CT scan done for another reason.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632385\">",
"      <span class=\"h1\">",
"       What causes a single pulmonary nodule?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A single pulmonary nodule is caused by either:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A condition that is not cancer &ndash; In most cases, a single pulmonary nodule is not cancer. It is a growth, small area of infection, or old scar in the lungs. Some medical terms for these things include &ldquo;granuloma,&rdquo; which is an area of inflammation, and &ldquo;hamartoma,&rdquo; which is a non-cancerous growth.",
"       </li>",
"       <li>",
"        Cancer &ndash; A single pulmonary nodule can be lung cancer, which is when normal cells in the lungs change into abnormal cells and grow out of control. It can also be cancer that started in another part of the body and then spread to the lungs.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632400\">",
"      <span class=\"h1\">",
"       How will my doctor know whether my pulmonary nodule is cancer or not?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To help figure this out, your doctor will use the following information:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Your age",
"       </li>",
"       <li>",
"        Whether you have other symptoms or other known cancers",
"       </li>",
"       <li>",
"        Whether you smoke or used to smoke",
"       </li>",
"       <li>",
"        Whether you have family members with lung cancer",
"       </li>",
"       <li>",
"        Whether you have worked with or around a material called asbestos",
"       </li>",
"       <li>",
"        The spot&rsquo;s size and shape on the X-ray or CT scan",
"       </li>",
"       <li>",
"        Whether the spot has changed over time &ndash; To know this, your doctor will look at any old chest X-rays and CT scans you have.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Based on this information, your doctor will know whether there is a high, medium, or low chance that your pulmonary nodule is cancer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632415\">",
"      <span class=\"h1\">",
"       What if there is a high chance my pulmonary nodule is cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If there is a high chance that your pulmonary nodule is cancer, your doctor will most likely do surgery to remove it.",
"     </p>",
"     <p>",
"      Before surgery, your doctor will order an imaging test called a PET scan. For this test, a doctor puts a substance in your vein through a thin tube called an &ldquo;IV.&rdquo; Then a special camera takes pictures of your lungs, liver, brain, and bones. A PET scan can show whether the cancer has spread outside of your lungs.",
"     </p>",
"     <p>",
"      Also before surgery, you will have breathing tests to make sure it is safe to have part of your lung removed.",
"     </p>",
"     <p>",
"      After surgery, a doctor will look at the nodule under a microscope to see whether it was cancer. If it was cancer, your doctor will discuss possible further tests or treatment. If it wasn&rsquo;t cancer, you will probably not need any further treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632430\">",
"      <span class=\"h1\">",
"       What if there is a medium chance my pulmonary nodule is cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If there is a medium chance that your pulmonary nodule is cancer, your doctor will get more information about the nodule.",
"     </p>",
"     <p>",
"      If the nodule is",
"      <span class=\"nowrap\">",
"       1/3",
"      </span>",
"      of an inch or bigger, your doctor will either order a PET scan or do a biopsy. A biopsy is a test in which your doctor will get a sample of tissue from the nodule. Depending on where the nodule is in the lung, your doctor can put a needle through your chest and into the nodule. Or he or she can put a thin tube with a camera and light on the end (called a &ldquo;bronchoscope&rdquo;) in your mouth or nose and down into your lungs to get a sample.",
"     </p>",
"     <p>",
"      After your doctor gets some tissue from the nodule, another doctor will look at the sample under a microscope to see whether cancer is present. If the PET scan or biopsy shows cancer, your doctor will likely recommend surgery to remove the nodule.",
"     </p>",
"     <p>",
"      If the nodule is smaller than",
"      <span class=\"nowrap\">",
"       1/3",
"      </span>",
"      of an inch, or if the PET scan shows that the nodule is unlikely to be cancer, your doctor will probably recommend monitoring your nodule. He or she will repeat a CT scan in 3 to 6 months.",
"     </p>",
"     <p>",
"      Your doctor will also get other information by doing an exam and ordering some blood tests. Further tests are based on these results. For example, if you have a large lymph node (bean-shaped organ under your skin) on exam, you might need other tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632445\">",
"      <span class=\"h1\">",
"       What if there is a low chance my pulmonary nodule is cancer?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If there is a low chance that your pulmonary nodule is cancer, your doctor will monitor it. He or she will order repeat CT scans. How often the scans are done depends on your individual situation. Most people have repeat CT scans done once or twice a year for about 2 to 3 years.",
"     </p>",
"     <p>",
"      If your pulmonary nodule does not get bigger over time on repeat CT scans, it is most likely not cancer. Your doctor will then stop ordering repeat CT scans.",
"     </p>",
"     <p>",
"      If your pulmonary nodule does get bigger over time, your doctor will probably recommend surgery to remove it. Before the surgery, you will probably have a PET scan and breathing tests.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H597632460\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/34/35363?source=see_link\">",
"       Patient information: Lung cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/57/25489?source=see_link\">",
"       Patient information: Tuberculosis (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/11/43186?source=see_link\">",
"       Patient information: Breathing tests (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/23/24946?source=see_link\">",
"       Patient information: Multiple pulmonary nodules (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=see_link\">",
"       Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/14/32993?source=see_link\">",
"       Patient information: Flexible bronchoscopy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=see_link\">",
"       Patient information: Tuberculosis (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/1/23570?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87304 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23570=[""].join("\n");
var outline_f23_1_23570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632370\">",
"      What is a single pulmonary nodule?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632385\">",
"      What causes a single pulmonary nodule?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632400\">",
"      How will my doctor know whether my pulmonary nodule is cancer or not?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632415\">",
"      What if there is a high chance my pulmonary nodule is cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632430\">",
"      What if there is a medium chance my pulmonary nodule is cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632445\">",
"      What if there is a low chance my pulmonary nodule is cancer?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597632460\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/11/43186?source=related_link\">",
"      Patient information: Breathing tests (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/14/32993?source=related_link\">",
"      Patient information: Flexible bronchoscopy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/34/35363?source=related_link\">",
"      Patient information: Lung cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/3/1076?source=related_link\">",
"      Patient information: Lung cancer risks, symptoms, and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/23/24946?source=related_link\">",
"      Patient information: Multiple pulmonary nodules (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/35/39475?source=related_link\">",
"      Patient information: Tuberculosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/57/25489?source=related_link\">",
"      Patient information: Tuberculosis (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_1_23571="Linear gingival erythema";
var content_f23_1_23571=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F62628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F62628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Generalized linear gingival erythema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    HIV-positive individual with pronounced and defined redness at the gingival margins.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23571=[""].join("\n");
var outline_f23_1_23571=null;
var title_f23_1_23572="Methocarbamol: Patient drug information";
var content_f23_1_23572=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methocarbamol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24677?source=see_link\">",
"     see \"Methocarbamol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/59/40884?source=see_link\">",
"     see \"Methocarbamol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F194398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Robaxin&reg;;",
"     </li>",
"     <li>",
"      Robaxin&reg;-750",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F194399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Robaxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702495",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methocarbamol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703915",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shot: If you have kidney disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015735\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may change the color of urine to brown, black, or green.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015737\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695723",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tablet can be crushed and mixed with food or liquid.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015739\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10854 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-183.1.191.153-340D2F8564-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23572=[""].join("\n");
var outline_f23_1_23572=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194398\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194399\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015730\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015729\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015734\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015735\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015737\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015732\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015733\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015738\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015739\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24677?source=related_link\">",
"      Methocarbamol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/59/40884?source=related_link\">",
"      Methocarbamol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_1_23573="capillary nail loop a";
var content_f23_1_23573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F60688%7ERHEUM%2F53495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F60688%7ERHEUM%2F53495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Capillary loop dilatation in a patient with dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 288px; height: 336px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFQASADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6RO0EfdGMZ5wR2pm3B5OCTnj+YHb/AD9akOCOMFfXPXtxSHBU5J5PJB69eM/yrUtCgDAycgHHqM+n+f8AHKMOO4x3x/n8utKRjJJGDxn0/wDrUH7wIGDg5JyDx/n8qQhBjuDjvzn9RQchcMeOnHfkcUBsE4xgc5/z9TStn5gc89jSQxH6jbznpg9+f849iaUAlR0x32nvj/P50gwHyMZGRnBz6/5/Cn4H19vamIY2VJJI65zjByR6/j+tKeCDxkckgAY/z/ntTj3znnPPTt/+ukGAQuGGQM5/z24oAaBgADggYCn6dD/nvSkbSOSB2/L/AD/nFLxgHAA7f5/OgfKM5OMdsnAx2/wpANIGAchR0BHIB9Mf/X/xqMA7FyAxIGeOpOeen19KlfB4ZumM56n/AB+lM568lsYyeT9f/wBZOcUxocuA24ZBOTz64/8ArUBuc/Lt4/D/AA+lVxJ++SJtwdwcgrkL/Tv+vfNSFmIC5OcZwRw3Yj/9f50NAx+4evT+HGfx4/z0+lNDbsAfN34Gcfl680vzMoUHd7+vtSLgkMrE9eQRz/8Ar4oAfjOBtBLds8YprDtn5/8AH/JoUALgfKASOnQdcfXjvxSkZUqM4zg+/wD9fpQADnJznJxwc4/+t/8AWpM8PuyFAbJAHAFBDDJO055IUduPzFPGScf3Tx26dDjr/n0oAawPTpj1Hf0qNAQ2BlV4PBPOeR7/ANetPOQGGG2nkbumOh+vb880jtj5jkk8dM9etABjGOoxj259vpTgRwSSAODg4Hv/AJ/lUXlkvkfLkFQAc+p/E8n86k3YHzHJ6YA4I6/gOP8APWgbEdgoBfIOcFccj/OPb86Ad+ecn0PYc04t/d5Pbp3/AEzSBcc8Y4+Y8f8A6/8A69AhHB2bhjI+bJ9f8cf5PFIiED5CGBzgZ6ev4U8AjGOuD9e/Uen/ANegkZBOOvbr7jj60IAIBHDc9s+vrShT7jb6djyD+n86F+VeMf8A1/5flSqQ3H3SOgHYUCGgMP4htx9OOv4Ubc4xgDPAxj8v8/ypeAMZ3Me5/wA8D/P1QEjPBAPvjP5UDAnJJIxg98Ekf1phDDcMYI7A5298569f6VIMZwo6+n4jP8qYBgYHQ9f1x/n8KQEgJBAJA68H/P0pAGBXIYnAGRinZ569Bg/0zTX5xjGSR39/fpTEg7cYxjqD/nFC4BAPHTPOD/8AWoTkkFsk89Pf0pGZuAOnpn17f5//AFgC4JYcfNzyRggU77wBxxjHzen+eKjAOTyDjjkce3+fanMSwyBnngA/5/8A1UIYrsMcFQT68Z//AFY/rSg87ck9Bxzn6+v+feoyzYO7jPbqR34xzxn/ADinDOPX14/zmgLDuOM8dcd+KbknOcjtjPfOOM/h/nmgsA2F5PXGeg9SP8KcVXcQF6YOAB+X+fegQhzt5yf8jp/Ohs7uhzzxyaUc4285wBj0oBDLwuc8nt170gEzgg5yoyeP8/5xTflUAAdOcY6/5x+tPbrzwPXrj3pjbgfQY5z2x/8Ar/8A180DQhXoActnGQMf5FEZDEgHPPPy9fbnqOKTBTvwckDj5Tjt6Dj/APXTscjHA/Ec02AAZ+UcgjBH/wBf/CoyrL04wCfkX3/w/wDrU9CGOCMrjp14/wAKX5SBkqTwvPPU8UMYwqXHLAjJABye/wDn9ak+6oDNkDjqOf8APrTdw46ZJ6gcUmW3nsQPTBz9KLCHNtU89SQM9M01j8ueWyOuMk+nH1pCwIyAArbR6DnjH60Nv+YEAE8Enr1pWBDmB2vu+Y9Wxz0FNJ4OF3cHkd1Hv+X4fjhxBYsFHUAD9eMUdcgcnj+uD7UwGDjAI6DPTBHHA/yegpxJwduQ/QHqc/5/r26jqSp+8oI4IHU5pw4UAN0Hf/P+cUhhxu68e/P+R/kU2PBQMGOCuTnnt+vrT8jocLxyDnJ5pGKlQGbccAgY/LH9PpTEIANuAMZ4x6df8/8A16VSS/TDY7foP1OB/kITzxyecqP5c04YIAYfz5oAUngsPQAk/hyaRuAOeBz+NBxyS3IHIP8An1pGDHJ49xnP+f8A9VAJDX5DdBgnhuOfw6U1Q+PnOOwx3x6fp0z+lPJypAbpxj8P6fpSnA53YLHt9aLgB5JJGBnGMcdc0hbJZWHboDxx700ARrt4xnnPYc//AFx+NMzuRsg9eAeST9Ogx0/CgCftyTjr6/p/nr60NjJJwM8c9u3X8e1Kw6Y69c9DScHjj04//X6UCEYnA28DpSZG1gR8p9DSlSy5HUdCeevcd6Y21hlgD8uCDj6/4f55oGNZ8HaORngdePXjoP8ACpGVcEYIBPzZPJ9/r09f8FUbgOScjGR39T/n0p+MggEc8jnpn/P+etAXGABXIUjPUrnJxz/j0pcDryAPfnOBn+lOPQYOB9Of8/5NNxtAPp6df070AgLfL8+Pm59unP8A9egDLAliD65yM/X+lMdc7sAE9AQcfQD/ABqQDLDH54x/OgBCcZJyQBnPXafekORkdgT6H155/wA8e2KViVIzzjjj04/XFINoOQVPG4HqD/nFIB0jAAgkjt16D3P0piscYzn2AH+eP8acBgBWOT1x2J65/X9aQ9MA8Hrkf5/SmA0sR2B46jp3wKjCkD5nOGwx4OB9Py7Zpl7fW9ku+7njh7gMw3Ee341zl1490aEERNJPJuK7Uj6njPX6gfpzQWoSeyOnQGPA3ZI6bsdeP8f1/OT7xGcEZweufz/T/wDXx5pe/Eko6iy09vL+Zf3h3Z98DsOe+CTWc3xO1Hzk2QWa5xuwhOBnAB59cZPbnrTs3sV7KR6urBD33kkEHr+H6dOalXOw7cAnnr0/H25rxpviRqnMgktVQNyPK6K3Qg+/ByeDkcVctPidqKSBLi1s5+OxCDd1JyCeD7Z/CizG6Mj1VyVY/OwyQDxn2/z7+lPQnJIOF7d/8/SvPrP4mW0qxi8sZoixAZk5259vyOM9M10Wm+MNBvywg1KMPjJEoMZ7ZwD+P+eqJdOS0OhPUgLxnpTQ+58HJK5zxn/P+feoxLHcRM0UsUq5xlHDA8Z7f5/Q09U25IXkcY65/wA46UEWHKfm4BJ6nPYf1/8A1UpHTIP9P8/zoHJJOST6n6/5/wDr5pSASSQCcBu/HuaQg4IXkcjsfpSc7doIAGMgn8P8KUE5+YkY7k4J9/50vBJ4+b09D9B0/wA+1ACEbj68/wCcUDIzwRycDO4n0P8A9alyM7cMQPbqOOP/AK1JsBzn5hjHt/npTEIu0gKSpJ4GBnHp/n/ChuSXwMg5znPr/if1FObcw7ntz1/Dj9P54pqjk8cZ7HAz0H9KBiHJzjJAx78//WoTcQcL8vbOeD/n/Clw23IB68ADp19f8/ypdvXKnB4/z3/yKAG4AYnkEZwR2/H8O1B+WM9h05HXr/nNDMTyhDYPGeB+PpSMDzjoACMcevf8B/8AXoAcTwMfMpHT/D2/x+tO55OePXrTSeAMknHyk9ScdfrRHwF+U4zgjHTr+dMAfIGchW69ev8Anim7cZxxzjgc/QZ/pTw2PmJGc8ccf/WpvBBI5xwRjn8/z4pXAcpy3y44Iwf8aUsAOeRkdsH/AD/n1oGGJzg5PI7H/OB/SmsGDcnr1Pf+fSgQ7uAMn6H60Ek+w6g//W/DNMPHQhRnp+fH8/z7U7rjAHTof8f6/wAqBiHnnPJHTH+f0pFJUnB3AYICnn/PGf8AOKc27kknJ4wBjP1oA9TznkDPHv8A/Xo6AIQQOM9sD/Gjv945H3jkd/6UhPBO35sZ/wD1+lZHiLXbTQrUzXbr5rHbHGOrZ/p6njvSZUU27I0b28t7CBri7lSCBQSzucY/D8uP/r15x4n+Irktb6MrRLkoZ5B8xBP8OfXn8utYkh1vx1fNNK/k6dHxlziJMHGFGMlsjt0B9K6rRtA07SHE1tAlxcqf+PiUhmGRn5VxhQfYUOy+I6IUkvNnFWWg67rJM1yjokpP7y7Y7iD/AHU5boTyB1HOetb9v4KgiH+m3k00gxuSNQi5B6d+DxzxkH1wK6uRh5gV8s5DKWBJ9c4Pfr1/lT1s5nI/5ZwggAcgMPp6f0PtSc3rZG3Lb4mY1r4e0i1BA05HKnA84tISDjjnjP8AnAOaviC2iAVLeCNB8pVY1Xg8Zxjj049B061pR2CADe7gHnAXt/Xr+v4CYWEayDIJwQc8nB49fw47Y9aV33JbpmWSuQQkW4k/wAN68Ejn6/Qc84p3Gn6bcZS406zlBOdxgA9PbuABjj3rebT4vmx5oxwQGwMdhj/PrUbaYvHzPyfuk5JbP69f6n0K5pLUf7rscbd+ENHuIy9tFcWp4Aa3ckDJyflb0/rnp1wrvwJeRSsbO+t5gqjibdGwUDjJGcj27fUZr0WazkjDFSHjAAJxgqMjoe57D6fiIGfy1kaTORkMSNu05/mDjB+n1qlVa3H7NS+Fnl89pr+gM891DeworZM8bFo9uOuU4HA/n7Gui0P4mXNsBFq5hu1C4aVcKT168+3X0zXXKTEWIYqRxuVTkc8jjPvnHAz9KxtX8MaRq2XeFbe4yWSa2AUjkckD5WycHH5HqKalF7kypytrqd1o2s2OsQmXT5g6quWDZBUcnn9efrjvWkvAwO3T/GvnrUtN13wbOt7bSs9pG523kQIQf9dF4256Ht0wT39N8FeO7XXQtpdhYdQ28Anh+nI+ufyz0xRbY5p0usTuF6jPPbI4pjOduByQfp/+qhuc5GRyAe/5/wBaRl3ID1HYj+Q/T/69MySF/j9scn8+eKFPOW655zzxn/69Jg4QMcHuSPr/AJ7dKeB8wHGeevP1oACNwxkA5xuH9P8APX8KCMd8HP69KaDwpB4Ocnpj/wDV/ShmBO1hk9en5DFAhT3JXGRkkDPHp/n0pOByccHr6e+fw6/hTiOwzj256j9aa7YJyDnOCP6/0oAcAASM4IPv9Ka+DnIGCO/0OeKGIGATkbgOef8AP1pueGywx0yT0PXmkOw/ODt55BA570Hp8nzfrmjYMAhRwenX/ODS7Qq4bAXsD35piEP3iQMn+dJlmycc9mPP+R0pfz64z1/Kkzn+Hg9zkH/H/JosMBjH95dx5BJ9Kd1Bwe54B6f4nv8AhQeSQB8xboDjvzx6Uu0bdp6nsRzQIRiDgc85560jHjPO4+vOfX8f8BTGJJ+VuCORn6/0BGelMbhdxAU5G4H8zyP6e1A0iQnG4nBXB3egHvSBvmxyOcDtg+ue9LnIH8RIB4bPvn/PWobq4jtbeW4mIWOBTI7Een9elAyj4k1u20PTmurpl/upGTzI/OFA9f6Z6VwFjpl54iuRq3iVZIrZs/Z7XJDyj07FUwBx1Yeg62tPtW8T6kuuavH/AKKrH7HZPzuXjEjjptI6D8emAekQNdu7EkjID85wRxxn/wCtUylY66dNITy95ihWNY1CbV2qNuMdABwMY/zxU8Vm75MknzckBTjjnnP5nHvj0q1FEsanyxt4JyGBJ7/0/wDrVMoK4+XGCSB1xxn/AAPvz3qG7Dc7K0SO3t0iOFjGeAMHn2/yOuasYAVsjjJ5b+WPX/Gm8BeTwB656/5/nSq65JHDAk5GM4/yf1oZk7t3G4weQQCeQOceuc07B3j5cE/h+vp1pgmjVsfLjsD09/fqOlBnjAJ4C8cnk/8A1znt7Y9aY7PsOABwDn8ueuR/n+dKxCqS3Hdueo//AF8e/P4MEgPqeSDzwO/+cf41Isygggnnn05x14/z1oE0yJ0Ys3Az3IH05Ht0+lQ3VqkwYkEEDqpwcdueoxz/AJ5qwxUo3I47beMZ9P8A9fpTSeSQCfXjOD/noffmpZUW1sZM1tNEGdV3KcZ45HsO2AMf/XzUCEMIwd24rw3IA46HjjkYGenatkDklTtcdx1U+3+f51XubSKaNhlVZv7vGSTnv06f41NuxvGr0kZ6lcBNud/y5I4ORyre3Qfl1ya8/wDFPg1oE/tHw5HIixAmS0jU/L6vF34wMofcr6V6LOjxFvMULGckugwP/rYH9OTURVdwO4dM4zyOcdT7/TJ5q1JobjzaoZ8OPFK+ItP8m4dWvYQN2DjcvQEev1HHp6DsBjAwQ27qcf59/wD9VeP+JdFuNK1H/hItAifzI8y3drEMbl6tIoxx/tAdiSMHNeh+EvEMHiLSIrqKRTNt/eordCMc49P8+1arU46tOzujdYdD19P15/zjrSgAkZ24+vB/z/nmo2YhuvJ/u9fb/wDVSjnAHJPPH/1/60GIucBeAM8kZ6UqKSeeB049Oc8UgOSCccgnJPUf57/Sm7TnOe/Rv8/y9KAHk/3fXgEYH+eP5UjKG4LZ79ecev8AnilGeACTjue/+f8APNNL4QnJYEYwvQe4P5/nRYBV4T5htJ44PY9vr9acRjdnqeeBzj/OT+dKOPoef8+/HY0ZHUdRyDj/AD/n9QQq9OBjvweOlBz/AAdc9iOOvekB6e3Y8Y+v+fzpQeh5x2yOf8/WgLAQCBgbs9AD1oYA/KeSTg7j/n/JoPJ65GR1/wA/5/KhsYAXg57DPPH/AOqgBpAPYkZPf1/yP8ihjjdz1OeM/wAqTaTk4Csf07//AF80p+6QNwHHHp/SgYEHJPXB6Zx+tQ+WxYZJwDkYHQ+vt3/WpQvzHghicc+oPFIOmB7H1z/nIoGM3AZx168Dj/Jri/ETr4j1U6bGznSrNs3hQkGV8HbCpzz6tjoAOhrf8S3k1jpjCzQvdzN5UAyFwzcZOew6+g9uKxbKBbK0S0tMykNtMrZBkbqXI68nnHYYA6ChuxvRhd3LyRPcy7cgLj52VSF2jHC49OMdOce4q9NJFahQSUwDgKc49/Tj15/IVHZr5UDO6kBm4AGOAP8AEkc+1VBIZXWQNu3fcwcsMcj6/wD1/WsGzo5eZ26ItPct0UbSOA2eCOBwfy/T8GmZl+UDLbT16AfTr61AV/LHUggn0z7dhx+PWgcoqsNy5B4XjjnH5j9DxRsUoImkmkI37mUAk9QecHH49vzpu87hvIKcHBBJ4xgnHbpj0P50irlhwAwbAOMlTzjGe/8AKjLMwC8g4AGcj3/x9/bHLfmOyQ6MEhcH7rAEscg9sE/p69+9SIC5UfMAenfB9Pr/APW+tMjBEucFO4JJPQdh/wDrwPrmplXJAwSScgDnscfljFPuTJkXGCXBDcnI9fbI68dPc0u0kkHaW6gAZz/9b2HXJp4bg8kDcBkf5+nPalK4Xjtk4A7/AOPXvQK5E0hGX3E85JPfp/nPv17UPIwzkngDqMZ74zyOmTSzKVDZzlQOSQMDIP4dvz/GkK4Ysvrj3X6enrxSHoSq4YEDcXPBLdCf8/SpdxOSc4J2n/8AV2//AF/hWDleME+2T3+v509Xbd8wOMEbjxgY6/8A1vel0IcSU4c7JOc/e3Ae/b9f8Kqz2RckwgBsEbccZHp6d+fUZ71YyANrA4JxxgcjqPrz+fXvU4G4BT8oxg8cZ4wOe39TignmcXdGG29J0bLrIuOQcYPvjrnpn349K4vUrV/CHiGLXtJjxpV04N1bRgqIyx+8B2QnIA/hJx6V3mqxhJoZH+6eMcfNx933Gc/pVOWCGWKSGSOOSORCs0cmSsiE4IOfXPUjr2z0qMuV37mrjzxTOksbm31CziuLZ/MgkXcCOQQevPr/AI1aK7iRwDnB78f5NcH4DMmjanNoMsk8sGzz7GaQ5Z4iT8pbplTkdfTqDXeA4cKFAHPT/PA/wrY4JKzsIgITGCOSSVAP+f8APccyDBBxg5+Ukng+g/P/ADyaaCe/tkgf5/z0pcYBHPpyaRI4jkqAepJ6cdev5/qKTAck55zjJ/T/AD/ktPO7HTnAHHr+XenLksGJJzkjHfvSAQOCSTuJzj1P/wCvpxSlRvyG5HHTHSkKqpAO05wOeOPTpTuCWBJ9en+f8mmA3O4A8nuOAfoKU8E5Py/Xpyf8/wCeDJJHPAHQ9eO3+f60DGcYPJ4zjnr/AJ/GgB33DyWxnvyT7e1IGIBy2T6EU0Agja3Xnt/P1pBgg5G7PPJz/n/PWgLDyQvVgB+YP4D3/wA9KQc5A5HOBgUFecEnA9+T/n8fWkYYHylF5HUZGM8jr14OD24PPSgQrZIwCcnkEDOaj3bTkA4x04Prx9eaG3FjnnPJI/z/AJ/E1BqN2thp8124P7tSQudu49gPqe1GxSV9Dn9Wu/terz7WHk2IESrnGZX5Y5/2V4/4F6mpdND7d4dQRnGflLe/t/8AWNZpTyUECkM3LSMAfmdiSW9hnpzWzosI8jziwy5PG4EAdMdu35ZrOSud9uSmOuVaCw8pyu8yEjJ6s3OPoe/eqiAkBmRwcZY4BIPpuxjjPH1q1rThIY1AIGdxyfTAxn34yOpx+NQQrgEA5GAGDDHHfn06889ahrqVD4b9xjAbGK4GMgcHA+Xjp047+46Gnpgx7kPHG0khcg46dsdOBwRjqKCMbgFYHG8hic5znnvk/pinhWDE9CcnAGM+4HX/AOt6UFN6BFyFChTj+Hn0Pt+WalVQZCM7gAFOR2zzkHj/AAz6Zpi4wAMFed3THT0/HpzjjHan5zkEDaG3ZxjjPTHp0wfpTluQ9xUwHw2AwPQ8ZHucenfrTgBtXdy2ASGHB+ufx/pSISvJXG1gTjgZ79/174PNPH3doALZ5Hv/AJ9fx9SyWAGDgfLj9PbGP85zTwPlYkgbcAkcfh+AyBmmAjy8E7uCAuev+PPcZ/SphgYJzweOec++P6UIhlYoFYcZZWzkDAyfbPT9ffNNkyrMec5x8wweucc/l/jUrjBD8HZ8oJOPbHHqfSmyL8uAw+XBA7fQ/px9KRaZA5AbJKncw6H8l+vU9zmnINmSOxyCoxx+H1zjr3pGT5iu4gAgn88gfTPP04OcCiIleh6YIJIznP5dM5/ySuuhfQckpjxtKgcKrHA45Hvnp0+tW7aVHX5ScgdCTgH6f56mqDDrzlChYAjaWHA6n6j3GM8UW0mHGV+U/eGSNuOv8qXUmUFJXJdRXCgoMEsOuMfj9CQf/wBVU3i8tAW8yLbzjsPx49fwq9LF56IwIGCpDAjB7/Qk5P5VWkLF9jEE/dzkkk+3sM98cUtbBB6JGTe7YWhvFAM1q/njA4ZcYbjvwPzA4rtIZVngikjx5bLuU9eO31rlCPs8mXwMKfvHaSCTkZ/T347Cq3w/vZLS9v8Aw9cynzbNz5HGN8JGUb2O0it4O6Ma8Nbo7bICgEHaflxnt9f6U4SZ685OOmD1/wA/5zSKxK5yeecAED3oU9vlG3/P+fxOKo5iQEBC2f8AayRSKcOR95s8DP8Aj70NtH3vl57+v+NIThXzjHT09/8AP+NAhwIAGemc8/z/AJ8UMOTjPX1z/wDrpc/NySpByT/hSEYU8dOcDjH4f0oENPBUZ/I/l/n2pQM7sDOeuf0puWIO7nJx6/570HceTnrnBOc8n/AUDHY2nIHfAz+HXP8AX0oB5A42H7vOM/hS4A5z9T60Ak8EAcYK5zjPahAKvHI5Ge/Tr/n9aM4UEk89zyT6UzJAO4rnHUn+dJuwTydxOMHg4+nUfWhCsNmI7EZyBg9O54H+T9KwNeuRPex26gGO3Pmybuhc/dX3I5btjit2V0jjkklI8tBljjkAc/0/OuUlYqrPN8sk7GZwSDg5+UD6Dsf1pM6KEeaRDKD87uQqFgechjnHI/DHTPHarlhdPCzuGB+bDNuGM8Y+nABzVCRy7EukghCdBkn16nnnOc9Rk56c3tLjhYy/acouCq7WwCTg4PTHrjg1m1fU9GSSj7xa1DE6LKNwQfMu1hnO7o36/rTLbmMrsxgDAGfzxj6e/AqNTuikRFkDOAQnUh+oH5j/APXUdnIpChApDKCFVskdh9eaHqZqNo2LWCIyVAwRyTyAfXIHp6+nWl2YyhUJyc4Iz7dR9D+Az0zQu0gZKkbeVPP689931/CkTK7Np4HHAAx3Hfr9fr3yJeoh6AljwQwyBjqvrj6e/wBTQOHXjdhuncnPQe/+R3oXZtXONuDwe45zz3/H86Vt2Qp446ZPJHr/AJ9fwbEx0YBK5xlwFBVeDjt+Pb3qXAKc42kckqcn+vtjr9OcwxYPJPXgjgA98H9fz7YqU8ruJOSc4Oef89Pw/GmQ9yTJwSPU5wM59c/yz/8AWqQtgYLfd7g/r/OoUO8Bs7j1zwD0x/k+1SjjPzHoecdOeuP884600ZsYwGWHTBAJHOM+/pj8sUyTAznA4yQc/Uf0/M+tPflju7YyWPTB/wDr0SEhGY4OPQjt6en/ANf1pWGitJw4AyRwQR1J7fgPTvmmA7MjrtB5HHHbP+Gc4qSRclwwGM7TnpwRwe3rUbg7CTyPRiB9ef8APtSNUIQpUq2AxPpz06HHuf196imb5vnPHUDGfYnBxn8fwp+CZtwzvC9CCO55IPp6ntnpzTJuAQVJXBbkkH05/Un/APVhWLW5eUs1ujZ5b7xB/P8AH/Gqbgxb5Im+bsP72T0/+t+vpL9o/dw5wAwIU5645AH8/wCXUVWubhnHlqCAFycAHPrx+IP05+sN2ZMYu5W84vhs7W+YjBB+v6k889PYVja7ELbUbHXrQHdaN5c4U5DQsTjOTnKM2e5w2e1aeCknBLEYGO+ecn06Hr6fSnI6yIwcBoyMMARnkHIB7emPc9a1puzKq07x0OxRxLGHjGAwDDJ/X8Kcq4cE98Y+nX/P1rnvBU7LYTaZO+ZrF/KBJ+8gxsYZ/wBkj8umevRtjnG0c88dO/P6f/XrXyPNejsJGgC4Vc5AxxgnjgY/zmnjjnapxnoM5/z+dDDIYEcnOQe3Gfzp2QG4PBOMDj8P8+nWhEMbgg/7WfUY/wD1f54pAvDDtjjPcc/rSj5eCOPXtn2Hb/P1pc7skkHPTHOf8igBoOO3A5yOPekODkZHP93HX/CndcEenB7fSm4+VlwCOmMcY/z/AFoGKpx1OQec4/z7U0p6kYHv096VfvswPJ49PzPrTsHLcfnyB9KAEyc5+bqe/wDh/n6VH5YJJ27s9Mjr/nmpTz0I6kn8e/8An9OajL8EDknkgf0oBGX4hmxaJbgBzcOEJJxhBy38uvv+FZLs/ms2cNyduAGzxj34Axx3BBq7q+JdUWRuPKi2cE9Xyckj2H5Z9RVIthRjc4Jx17kdvTr7fQVEn2O7Dx0KbpGJC7B3facqDycevocY/D65pbEQTkw3DiKPOQVHIGOeTznlT7ZzxxU93sRDGEDk/LneTsOBnk9O+Cc8Z9hVd8RSoH4DdNo3FevPOeO2Ov4GpTsdq96JtqLdgBbMgQAsBgt9T9ATyPbFUiVZnCAsjHIBADKSDnPv+faoYD+7TGd6jJUgnjAHP94duMjj8g7UZiGOSc7FbknqOB/TPPahmShZlgSckg9+nqf4cDsf8/SQMQjAY+7jB6+v4nk8/WqccuApB+VgUUgcH2/TqD2JqVJNiIFP3BgbRzjnAB7ZOPxx+KQ3EtKx3cDOCcY9cn8fzHfmj+HaQGzgcAEHv+A4xg56ioFbqwYcAgYAHfj+X44p4cA4GMF+NzdCemOmece/B702Q4kgOdmR1xyOeuBz7/y4qYBcDcOPfv6+57VWiwuFGFCsACT7e3Bz/nFWCoGAVKnPQHHOD+R6j/PNEyJsjYcjnofUH19u/wCVSj5skE5J4469uB+f5/nGobOSVJ64GTjp+Qp+Tt46Z5Pr9cfh/wDqoMWNBweGzjGB1yf59B+p7Ujnccg/TpyM8f4/54HJJI7ZDc9R9c/54pkx5boQOMtweDn6+n6c9DSshpEbkHlsjjrg/d9z/n2pvBZ8qSTkEjPBB6dfX+tMcAMPlXGcdRznPX9efSkbILMeuCPmGMcDOSePbP8AgaWhqkCpuU7QGU5PA4yRnpnv6fzNRzHKnHzBhwA2fx7Z7c9c0skiAsHO7A4z7dj9KiErlsKCC2cMuOcjPfsOw/n2L2LSe4iuwlwzEt6euDnsODkj8+neqnmsp3E5BJAw2BjOew9e4zjj0NaUqJHbEAAYGw7x+menU459cdqx5JGBCKB1P8O0nnnoOg44Hfsai12XT97oPlmXachwcDjrtHf15zk8fhzTlBLruVWfJ+XPGMnJHoMenXNOt1SWQkZdSd2M8AepPX/ED1FQsp3bWw390nvxxnp265646dBVLUbtsXrBvJ1SyuWIJmH2WX0cdUYj2Jx9DXYZ7/MM8nn9P/1VxChp4WVCQz/OmQeSOjHI+nPvwM11dhc/arSOdgBvXPHIHrj2rVbHm142kWi5UA9R3K9B9KXgg+g/L9P8/SkPMgBwT6+vXn/69KD0yTx3zmmc4HKjGWBGcHjI/wA/rTQSA+Seo4H8s+tOA4z6ZzxyPbH8+9JtONo4PYen4dutAxQTjqRnnp/hSNgdSMA/5FNXJAxtPHOD604Zx8x5znHf2H/66AFweBk59c5IIH+fypmARtHU9D07CngZUAEEbeDk4Hp7n/P1ofAB4OD3P5+v+c+9AIQkgkkHGc85z9CPyqI5HUg8cnpxx/n8qldduQPcADtx2/r7VBKdyuVJ4z69h+v+elCGjCum3TTM5+9IxG4DGAcAeh6A+2euKrStuV5Cd4Bwz5A44znuQfU4zx7VK5A2jllYZLE8Hnt7nj6dxVR8ktlQR95XySRxyOgHT19sdKyk7npUY2SIJCzSElgxBwcHkc4xyOf6cDFOwoWRvmXAB4GScnv6c568etDqjM3mBVIATIGeMEjtxj9PrSeVl3VeGfOTnOT1Pp+Z7c9qOh1XXUXzEWQOhJV15xxjjp3wc9zyOvFZesTs1q3mlFQts3LwwbgDn3P16nODg1dmJ8oEsSeduSeM46Z6cevofSqOoSoqRtcCMiQ5I7rjOB14zgc4zkH1xWVR8qLgtU0S2t3ILNd7AtxjoARkcfTnqMirq3kZC7JWzGcHjnJ4+npx0z1qlZTKUWBphJFngA9QV6H25+g5GO9O1LT3WNHjcI2DuY5yOpz+XXvwKz5pxV+hLtez0NK0uFk27MEgfMiAHp/MdOOp9qspu+ZC3IABCjp07dev+eBXN6Zut2wY/kzgKTnBHPJ9AM9vbnrXSRNHKo53JsGMD72f8QB61rTnzEVYqL02JYm+dR7bgvfHX6Y71Zj52nbhSR1z834fU9Pp6VDFCTtAI9e+5T0Gc9+Rz/KrCqVbooBbOMEeuT6jg+3pz1rZdjmm09idDkZznOeM5zz2/HI/PuKfIR90gF1B69v69OahU5wDyB1BHPv37HH/ANfOakdyoOP4m6Z4/P8Az9c0WMGtSFsEgbOGwfxHT/GoZn+U4dcY57gDOf07dfzp8gzvxwN2CQOM8c8exzUUx3Eh8rx7DbyT1/z0oNYoazKXJ+Q4HHPTsf19c59u8O/aBjbkALntjHr16HP889myK7Z+UnHAVeGB5yBj9c/rTnjZFd2ZVXg5YcKcYwfb8fwpPbU10RDI+QSOABhl27sYyf6+nXP1pIVKKJHU5wScn29eMDHX8+/KNsDKY/lRejZ5+v054/DHFRFwzEY2k88jaoOcnvx1HtjnioV2zW1yeaRXdjn5QMEkZIU9iMZ9uewxxiqNwW2/OcdAcnHHByDxxj3Hcjtm0CBgruVm4XjnOecj/JAz0qOVFdSRgEFRxkfr7knj2zzmq8gjoypC/kIyBgCCRk5AGecYxx2/TjINSBixTfvdtvt8xxnAHQdevU/rUJDrPG8Z8sjptTpgcDB5256Y5OD14zJGiiPAYqhBBbIIbkdefz+vsDSXQ0dtyxbSlRnACk7t3J5Oc5zx1H8u9dD4fcGCaInPlynAyehOe/Pf8PeufiJQFWLg4yR04IxyPTp+J681t6EwF1J5jBg6KTxjOMg579MfhzWkXpY8/Eq6ubW3BywyWPTuaXlgeR168cfhShQ2RyMnv64/z+FODDJ9+vr9D+n50zhuIoGCBnjuD254/wA8Urcqc/dxk5HQUbhvPTk+p4x/+o0cLuOOc4P1/wAKYhijC4GM9fT8fX6UpIJxwR069v8AP9aOfpn/APX/AJx9aMggnJ2k9Rz/AJ70DHBsnnnoTxx/+rNBJXnHPU8cn0FNDfTjuf8AP+fwoDEn1Hv/AJ6UCsKxOSDjGRnPSqt1/wAesuTnIx6H/PNWCCM89fWq2oYe0lGA7N/CR1GRx+X9fegpHP3TEeYASCfvAnHOOOfy5Hr9aqkgHLYIXJOxcfL68c84PfqO4qxdMWzgscHKgHG75ieM9O49qruNq4bgggHOO/T8cHjtgHnisGz1aastBCGMrDgMWxlW9D78evXAPXnikdm3Ersz6ZIGM57+/wCh6cYphO4I4yvUj5hnBxnbyOnUn/8AXTBu3EEFivy9iMH+fXt6DIHdepskRzna7ZXazqSvJb3JyOpH4+vPejePE4gWcAgfdGAeRj8x0x7cfSa4Kg/Iy7j8zHbyAMHJ7n+fr3qnqNv5irLKxUAlsD5c+oIHGMjP5EdeTlTWpvCKbVy3HGiEKs3UKx+YnnAwORzzjn69KnmDukOC5bhQwOTnPr3PI/KuMF5JBcNIMlk+VuMnOD0wehx05HB9Od/T755FVGy4UFgQM/4/w8f55Tj0NamHlHW5prEZhEZXO5jlSw65J5xkZ/8Ar9PTZsETy8ZAPzHnLYxyRnv7/wCNUNjFUfcgDY9OBjrnp0Ocemegq7GZgwfLbh8pyc474P4kZB/Cs0uV6HBU1VjVg2odgJHGRwOB3/nVpU3kbh90568cdT/XP6VnWkoGAMbeoGegJ4I/MdfXNX1ukiQEexA4BPOfy7/553Xc4akXfQcsYwOMZOM4znHT9On1+tOMY2E7SCcYxx2Hf6VEZ1bJ2kjPTHX6Y9/8ale6iETtuzzknHP4/Ufhj1xVIzakQPBGxGBjIx0HIz3/AC/M+1V3hVN23KnAzjHvjH68j298yvMhZuScHBwDnIPUfr+dMuJsnfkBuxyAcHnOCM4/oPzGzWPNsNwisQduc5Uc4+gPpyOPyqlezBmIjJAUHGcj8vT/AOsfanXMx34yoYdQSRn69+3X1H0rLmlaafqMAZ3enHXPfsPwz2qbnTSpN6sfMf3uAFGCSSuM+59B6+5pA43EMRnnAzk4yck459+feo3k88r91un3RkDjp7cY/D0PRisoIY8ZG4HYMlsjk46nJPtmktDo5dB7lzN16sB04BGM8+/P4A8+pJIwY8jg4baAeMHnOMDr15zx0zT51ACHjGSCAnAzjn6dPWq6OSpaSXkEtu5YgA5zj8uO2R9RQLUe+3ADMWXtn5ieMcA9Rz15H49HoxTaTnzFyQBkk8ep6e5+o65p3LnGHBJwQAeCMZxjknnv1602IBAoQYUdVLZ6Yzg/UZ9eOlL+v6/r7ieg5SMqAqgNlhkcA/Q+/wBT3rQ02YpeR7G5DfMG4IJ/r1z1/HrVEfLt2llO3BKDbgYxn+f9e9SRvslgkUggSBkOenPp9D6dOtVFnNWV4nYqSp+6M/w449xS878rkAnrjGf/AK/+e+KjXDAEDO4ZwSOeP8/lQrYHqeOcZyff0/DNaHnDstuydvbgHp9D/n+tAb5SWGMdecj8PSmlyGXapx1znkd+f89qeMgDPDDHH+e1Ah3OBljkjGQP88/54pMg5wRxxnqD3/nRuzg56ev+f896UcE/3/cZz/nNACFSeQeQO5zj60EfKxyTn1P+H9KMjABB9snqP8/5FGeCT3wD6H/Pp70IBWwSQc4z9O9U9SIa2ZGPBbHJxken8s/X8KtEnkE5IP8AU/5/+tWdqx2RRlWVVBO5icY468Hj0+n1pdCoLVGFMGdiTzznA6v1B+vYeuTmoXChTsdsDc4LPwBn27ZPTtkdeammkAGNvBIDZb06nPXv9CT6ciHJZzwA4bB5HU565PGRzj+eaxbR6kL2I5WCRyknIzzkZzx1GO46EemMiq8rKEdT98/IG9c9cf5x0p0hZixAKMQNpB57dD+fp1GeKZL98lfMGQc4PJHORn0IJH4Dip3OiKsRgkszliVJyVAGFPUnrwcc4OPqRmq99CZLeSORiHXoAMEkZ+Ydh7Zx3+lXEj8tZN2FKMANvykcZBAwO34Gs+ZZIyUd5EAACCP5sKB+GeR3PeqtdGsfi0OdS3aW4AaN1IG0DaecDoOmcdcZOePauj0nTdqhpQWYqSTtDbsj6dPY+gx0psNrGm3IxIBgYXHPTk847+h5x2rStQPLTyAGDKSMDuDjgeo5/wAkU5R7G1as5KyJ4ZFjEbCQIBkh88YA6898HOfzNWbbUI3VWjQJhRsDLg468fl+mPrQulMi5X5ixZhgAgnnr19P893WsAt4zlfmQ4/AtxyB3z/h3qWjklCLjd7ms10qlQCpUnhicjPbHvz2/lStONnmOQwyCWx94/Tvn8smsxvkVtz5OQcjgk5zz7d8j6cZqw0gCBVXgnAXv0Of8+hI4qTJ00tiWG5ikLAOM/dBPfgDj1HXn+WM1Kzy4VkBLKem3kv6fTtz+uKxreNvP4LMSchM8jjsB+PpznsK1g+y2jOFxtwDjAOOuMdj+WfWrsOpBRehE9y8bKu3O5sD5skkDp9emPy9KEm8wFCCGwflPB7fzznrjAPvUM8zzjIGQoUnIxjnoAO+eCOakt2IG04+bnhhjr2985JP8jxRsDikr21IGY7iQoAwcuMY5Hr07Y+mPSpCoQksqbAclc4AJxnGehwCceuDSsCfnbKFlDEehGT+H4Y7cDGaXaAd3mEKAR8o4I7fl+XH5LToNsZIi/K4XhxywGG+oA6fTn1BprACUMG+fIIYds9eR364PqSfcKQWXJOST8wyOSOpx2yOMc/zpiLsfa+SFwTuHXnGQD2zwSf50J3RSJU3FRtTqD9xSeB0HH16nt3HaJ0yC0YJ24YEAhX/AE6fkeTVhV3bso5IGWUHtk9z39s8d+gpJWIVgGPBA3BsEnuOe/p14PtVdSU9dCuMR4C7fvBSWXp26fmOP61IpZYVAyCOcheg6dvpwPp60zgFgSvznkLk54zn64649OadCS25mUt0y27ocnv9OM/likhyHDscAZ4GPTgE47k9/Xtio49zMQykggAn72WP4854549fansdyAk842gEYySMEdfTI9ufUmkPOYwiKcY2jpjJwMj0Ocnvk4604sxktDr4G32yEFTkZORwc9/xP8zUgOWz3HPJ6VW0z57CFl+4Rzjv9McelW8bRtXpnAC9+2P5Ctjy2KVKYxjI+YZHBP8Aj/8AXoPAbkkdcAgnjI+nYf5FCclgOh9BwRz/APX96QkHPIIOAT0z/kn9aCRyHIJDBh7fz/z6UEgLhvugjv3/AMf/AK9KVOQQSM+hpoBBB42849vp/nvRcBw56EE5HT9Me/vSj1JPPApgXkhfXjsP1/z2p/fGAQfT/Pp/nFCAY+MbQBjP4fX/AD+NUNWdlRSv3s556j3/AD+lXyQCAflzySDjP/6/61m60AIRuzhVJGD0x/nt0zz05OhdP4kYU/yKAueQCOR0JOARjtk5+uarTYwdoBHRRt4Py+/X6c9evWpJ2HnjGBnknglSM4OPxHPaqrNhm5HT5+C2B1HHpxnj0/PCR6lNDpIyd/y8jOEOD68+hBzjBwe2RzUUh2uzAM7noVwCfbHfqeeefzqVtu3dlWMf3z1xkdec46cn0HemsWAblsxnb8xzg9u/PPHPoOnIpbm0RIlWFPLXy/LGWwOclmJJyemSTgdgewIAeyqSyEPmToM9QccnHXjpx37dTH02sOFPPvnIx9e4498g8YkdRs+UAZOSvuecH+R9qpaK4xrWzyyF8Zzuxk4PQZDfn/8AqqWCNUAUNkAZGBk44wPTPbA9R75jRz5gAG5WPyrjJJ5IwMZ+meB2zTmbCgs7Om0OGccvx6Yxn3555pcw3zbEzqpOT94ehGBwcDHU9+PfjjrHJ+7C7AVQDIIJGCSMgdx/ng80xXXYo3gerejfXt0Gfc8ntTgcAFiw9CMBmAHOfTv79PfA9dWK1iGAyO6k5DEcBs5XuM+mevp71digIADD5c89cg+mc8cDp6nOaiUMM7eVxlQDxjPUD8f8etWYiRuVOdpxtUenAP6j/wDVSbd9QnJ9AjRQ6uwwFBJxwcZ9R246+oHoKkkk3r8vzOfQc7gPT3APB5PIpHGN24ZwSB6jI5+p/HHAPapPLyrY5Uk85xnpnrxkHHPbkdhVLzMW+rM+FWZwFUsgO4jPbHA+nPGfX1yTOR8jMSpQ45VeP0/z056VII9uQF+bhuOMH/4rnP4Z6GpABvIG9X+9u6EHpk/4nrik7lyld3KhGJCEOcAENjOT6nnpjr7+1Tvwj7SI/bOCvGBz1wM/rSvGqthxkHDHP8XJx+WP84prsQ285YEbsHJ5PGD/AJ/Wl/X9f13Fe405Eg4UDHyt7ds/QEfTj1NN2IUUHaBnbnk/iO4xn+tTINrcADbtySQ3PXP15pFYgkuSARtJ3E8j+XOR9e5wKL9WFyMcNlueeODwRjv+XP8A9bACuBkKcnbwNq47LgnHv9cfgjkoSUV8KvBBPQdB7/731x1pkv3mHmZPd+3Ye/HT169+tVuC1I1O2QfNgZ7c5wST9cD1pYgMGRVDKoORjccYwQM/qO3X6xFsq25VHO4jqOnTOPfqOOB6VOhyQcMSWbG3kjt0/ChFSHSORHyfMTnOCFz7c8ck59KrTqoD73woPJ3dcZPX06jHXrU07oisGIC7m3HGePQ9sdOPfHBqIsQXPIYMT8wxgdc+uOB/I+tNbEdDqPD5KWjhuCrsMg5zznIrTIJGcHC8f5NY/htmMVwvzKd4ODzjgAZ/L+vWtgkbcgZwOOAMf/WrVHkz0kwGduCc+px/L9Ka5IVi547kn6/5xSq+TnHfHfOPf86U/KxDYz78k+9CJHDkNnBHOMAn/wDWaUjB57nHP8v84ozj5iW6df8AP/1qBwBtAGOeDxQhDdoAOMAsMZA6/j3H+fqpIx785zTuV+7j2PTv/jTQMAjnA556f5/z6UAIF+U9Qck8H/PasvWssibfv8gf7Q78eg65/wAa1Fxk8ZOc+/v+prK1xhHEr7lBTnPTOAf8c9qTehpT+JHNmTzJuEyCQAVJG7kjHrjoTkAYORkgio2TgYUnHB74PrjuDkf56yyb3VCA25l4OeWOe2f4uD2PXOKryIABhVCgHCEHOB1HTIHbH0I7Vk/M9SApO1jHneMYHcgA9R7ZGPX8qQejAlkOXIGODgAY9DgcdOh6Zp1y37xmfBw+FDKB278+gz64x7YVldpCACQ3AyMnp2I+p9sE9uROhqhkg2K5OAFAXDNgde5PTsc44/HNT7CYyH3EEYORgkHgg4wMdf8A9Q5RU5GzzMsu4AEcjGM5PXt69PapFIDJ5eFG0YyMDJPBHOPXHp057nmDfYi8gFj8uUZSOgJI7jkfrx+IqWVAFA4IOCwBJJA/rznn8+9K/wA3UHAGMdMA8g8cnHTHHfinFN23jDHBBPGSQTnPr06e9NasV+pVUFULO+ABz6AHPBx0+vXpk5Gal8p3DAcknBJ6DAwc+3vUqoPkY5QZGPl56H7vufTH6VYRFZSXbdvHXG7g4OB+X6cdcA33HKdipHEcYXaCzHljyCOABz1A457HqO1yBNwBHI7nH3evOe3bvng8VKkIL5ZQCeeOQBj2z+X8sjNlEXAyAMYzyMKOvOPT/wCvVbO5jOoVio2/dAI4UEjaOnYdD0xn144puWUHc0hBO0MTtYnt9ef8+ls7mDHkkk5X0I//AF1XlBB+XAJ529CRkH8fT8fwJ5ERdyAjKlBt2nGFXIX1BHXPQ4PFAVNxPH3sDB5A47enufU5HSpFQEf3kJGWB9DjAPcZGM/X3pJM4YSkBVyxZgMKBk4OeOPx6e3Kt3LuRSvlmyp3D04Bb1P4DP8A+qkV8yAgEcbSV4PQnHpn8u3rTpjsYnjao5yc7QDxx65yO3eq7jY4QKVCgqcjA6e+MjnsR+dTctK6LG5TGjMVPbI6Z5yB/dH8gelMkIAZTuwDkqDz37H/AD6elMEoY8fMWAU4GePp+XTjH4Co0k3FSuWfBOAD9D045+b9KLN2BRsOYj+IfXnlW9s9uvHTHrzkXDM4DZdASobJ/wA5/ve/FNJA4VRgjfgHBOO2R+B49AOMUw8nYRjbnOMFcdzweOQD+A96C7CONrgBlAxgDcOOvc/h39PpQmCcuV3kFRuUjGR6/pk4PDevKuCxwhG4ZG3jg49Pr168k9qRTudMtlivXn5wOO/U4z0/vdPVp9WD2CYmXjlsDnzAOfXPbuOO2fzQFw3yM2cgAqvzKOw/TOPUe2KlOFGCV2oPvHkY65z356evtSf60MzKxbaVK9crnkE9QOvXrwPqLXQzlsbPhdxvmjC4XAZADxzkHHHHf26cCugVT65GckjufXHaua8P5bUpUJJfy+hOOnv+J/z06NQSAccjgbs8/wCf89xWy2PLrK02NI/2Rn6dfp39f8mlYAqQASDwMcY9Bj1x/nmlJxgHkZ45xkf5H50pxtPTd0z15GRTMxeQFB/LFC8gDA55yR/n/PFNxn7uCPpxz/nFSBfYjB7fp/n3oEIMcYzgcEn5fz/OmgDkgd8E85PHf+f/AOqgjnp1PXjpkUo+bqBuJOc8/wCf/rUAIrfMefTqf8//AKqw/EjFYcJ8pOCCRxjPI/U9eD0rcJyDgnqe+cVheIWIaE5bBO3rgMcZHP8AT8aT2NaPxow22gY6hAA27PXHGPU9P1pqoP4d+1gQccnceMA49wec8dKRgQEjORzhTggg4Bxxz3z9PqMkYC5Z8kKcMGOB7ZPYZ7flmsdmenHYWUAnapYSsgfIVumQPvAEA8j5ev4A00ZMrAqgJZflJ49j17HqMjj1qeUEjGThs5ORwdoGM/yz0qFjh12hXG4LwCMdOn4Y/LtjladTSNydMOm4EuAo5zk9vun175/wzTXC7kP7wDBGM4wBnoMce3t64pYn3BicsQcswPHYgA554/p07vAZl2FQvXJUY6n09Oe/IP1OTdC2GqAVH3c85PJ2/wCcj1/OnhNijBVtxJ5PJ7k/if8APWpY1bPBOMbcZ5yOD/8AXxk9qnIAI3lQSQCpOMcYAHfPP86ErkOZXQHgDBdiWBHy8+v6+/T2p8C9Pu7QRlewGBjOR04HrzzT1jwndyck46nHb1PQc9f5UIYwVwRtAwGzxj6/r/k4bdhN72LlupZUUMxzgBuBkZ4A569c9fyxixtBG4Njd8wIA4Hqf89/fNUopGY7R94jLYGBwB26Z5HP6VOAzkEZIGDjbz3/AM/h71RzyTuPZg5PmBQORgjp9Pb/AD0prhfmwAMDAHr/AJ4/zzTvKPlhlxuzn5ueT2x6/wCfoscLFg6428Ybpxz79fp9Kq9ybpdStchVO0kjJAJyO/HX2xVeRsBtqHIzhAeQ3pjpnpjt+VX5bdRGzDCkD5jzj069frVSZdgfg4UEBcD9D269vTv1pWuawkmUz8pbY2GG3j19Nv046+vTuIrkKFGAu0HkBcjr09h1/KrcgXdtJJA6ZHU8+h+h+o9hVZwG3DcG+b0yOvUjr6cfSp3OmL1M9pHTzSdvyn5wQflHGePTj+XY1NG5O4MGVRyRt7evHHt7ZHpUjRBlDptyCRGoOD2z6evbHOPwihPChGbK8CQDJPpjpx7jjipRrdND5FyAxTgjkj72Sensf8iiL+MnYcKSCex+nceuPQ+5p+/cyDeQD0LHIJP9fXoehokJAdmJIAYnPAXA9u+OMk96CPIaVXYFYF0VTgD+LrwB26/5PBajFckZ5LHdzyc+/YDjjpxSSH5DwPUr6tgYBB55Geee3saZtPPcbi2cY3cdWA5znH601uO2hZRyCMOwA4znpnkH0JJz+vfgIgAjJyCf9lvlB9D1OD0z17YqJCZQoVU+ZjgZA4z+OMt+uMgjrMWJkUM54XcFI6rnOB6DPr/jQtVYymrGh4fb/TyPMDAp049D/wDXx/k102SSDjr3z2/p/n8OY0KQf2iu0nDKzH24x+I/l/PpXyWwV5yRzyfw/wA8/pWyPMr/ABi7iW65HXgZB7dKYzbS2cAfX04p5wD/AHhnqRnPt9fp+tBUHcOoAwR7c9fb/CmZD+y455BHvzSDgEjpnrj86XGASBx156df/wBf+cUnPbIOcd+Pb/6/vQhCse/6jOfamZyMHrjoeaMr2HHb9P8A61KwXbzgoOCSe1ACuRhskgZ59a53xA6i6iZiQOjc4IJ/+t/ntW9IPmyQeCQPT0Nc1q7s104DAEOAQeAQD0/nn6YFJ7am1Fe8jNPMxbcwfGWUHb0HXPUHA68duvAqXmL7oKgA4GNuPUg4wB0+nf0qMttg3qQQWGSMAn8fw/GovMZl8whCx+6ODnA657DH+PSsj0YpslODJtwyo38IG0k8f1z19SKpyuu8ttRgwBIAwMH0B6DOOnfIzzkW2UGPy4huWTJHPXpwSR9M59PcVDKis27kIdpBIGM4Hr7fjgfUGDeFupZhDGJhIACSc4XH4nsCD+GfXFWU+9wFU43EFfu+w/Icn61ShIUcAKgThQDgjHQDrwD+fbrWhDl+QSGBwSMZJznB44P9Dx1qtzOehLDEVQgkhTnoMgHsOO2Rn8vcVKVIycZI469O2B+Pp7j6kbCNflxjGQFAHGBjjp+HtillcOMY3Bc4+npgdwf8nrQ+5g22yszlueWAHJ7/AOf885FCbWILYOF5A5Bz6/lx7496bt3EncSwXcCOBjBwevf0x659Ka8e4ktymcj/AOuDxg9fz+lD0NLIsQOCcb1yMZYEj3H05xz9KtRuwYYGFBP3WzjjoP5/j+VWKEZQZClc4IJB/AHtt/P8BVhhsO7ABUcdQT6g+/6DNNaGU7XHTGQ4x1GQOOBnuM9Px9R2qWF5OS6nJ4/M/wCfzqIOdwwwyCSdoI4zwQTwO5x/kW1mVEALDngdcdun5iqRlLRWsRO0v8Yy2MZB6/j0BH+elVmAc4LcY4xnoR2I/DjtV4yIzHbgnqB6DPH881VcK2fLZcYODn8sf5PXjFP+v6/r/gODKckCLjbtCEjA6be2OORzkYHPT3oWNnPK55wAcZB6EH8jx2/lK24yA5yOpPqOuARj05HGKjUfLliAAOuCQRgkEg9se1TZmybsV5Rnex68PnJwPQnrn8P61WdFZ8FsZH3QeD2HHYZ7/h1NaJRTgkcY6AHHTp+Ht2PbBzmX6N5aB3wHJDfITng4BCjJ5OCB+fUFQjzSSNYyCNWWREmUK2AHUHOO+Dj69PcdM1LtOwM3XABDZ2+/Trk4P+OMnJ0OwGn208cEfk21zcS3EcYzhNxGQSxzyeQccgc/dGbgmfa/Kt6Db19W+nTH/wBehx96xorz1RJsLgDJBYEkbs5/n64OR1PPJxSAEBfkfcCSMfMw4GOe/OP8e1ClsEHaVJ3YZcDgnr6fz/HNPcje2Hzk43MM5Ynpj+Q+vPap1BkJCqxRVTbuweQffJP6c+opBnK5H3/3m0cjPXp7jP8AXry4qWVh8wQdGPY4zu9/8jg0qkHLxjbk5VSQTwAfwxx344q13Ib0NHRX/wCJjBtJOQyjC8Z5PTrk5/8A111KsCCV47ED/OPeuU0BfM1GJnBDdcEdPlPP+f8ACur2jrwDnnvz9a0R5lf4wwDnAHGO1Kf7vB54P5nigDaRwAc88f57H8qY+GRsYAP8uf8AH/H3ZiSqMEZBPTr1/wDrUw9wACw6D/P9acDyAScgcjPH0pAwA9R2/wAP8+1AkJzu5yTu9Pyx78/r+NLnODwMYIOelNcgE9sHHTp6/Xr9KVQMtgHjOTnp+X1oGNc8seRjnJrlNRIaRgRtXn+IAkbsYH+f58dbjGcA4Bzx2PTA/KuXvtwvZnxhsnHT74B/Tnv2+uaT2NqPxGZON8eQqxthfmHIHOevQHHOfQetI8K9U27AAWCjIPI44+nt6dqsyRGJCGYFioBKe5PXPX19fXpiopMhSAxBxjrjgHGO2OO3sD1BrK9tj0YPTQZvV1I43llwN2Tgk9D3/Djn2qvuIIycOuFKqMsfbHTHBPX39KkkGFCsgYNkhjgckHr06jt3PBIpo+U/O4PAPTJK98fp+eOlS7G8Szb8lQ6gHuGPyqP8kHOffvV5G6DYd7dc8k56Z681nRMC21CF5G3HOeeB6D0H0q6gPUAbSADwSo4x9c+p/pyEndEVF3LaDjCnBc53L364PHP4daaoYleGzjK57jBwevbr+NOjdPLOOBnJO4NxnPX/AA796aJFYMRlgTjjkf8A6/8ACruYWeo5cljknAGRnB3ZGefx4/CiRRvfAPTBI9OCD7+v+TTUXa2IyOm4lOucdvXBz/8AWpQVLcL82dx28454/HPfv+dC7AwjThdvB5bGOpB7fzHboPSpGJQ4DABXByG+7zjPHcnP/wBfqJofLBY/uyuPmPb8SO3Ofxpl8o8yNc5HOFI4OOPTjj9DxT36kKV5WCLgtnHBOG459cdu4/8ArVIX3ZAHf1xn1/x/Km28IKk5KkDdkEdN2Scjp1zn1ye5NWGtgqEA7Dz0OOnf+QpqxEpK5TbJLKOOT14x6ZHr/wDrPHVvmgEnPTjJ6Y9QPyGfpUk8TImA+CvB7cdx7H9P5isSQ5O4MV5DdWDfXt7fjSdzSNmPOMFtoyDgDPXk5P0J55/+vTixBw3XHU4x16A+vT9DToj8vy5ZeThTgH/H9ahds7SMfMNu5lJA5wQfYccf4HCGtxTlssEB3AHPQH3H44/P8op0yj5XORgqTyc9FI/Ifpz2eWUksVC/iSSSe/qfcf8A16ZIod+pBbqrcdsAfTnp/kq5cdGVH+c5ySenmMdx6ccn0/nj6VWIG0PtUr1KnGBweOvP06j6dbM6/NtbG5eC2e2Onf1x+GevNMC78qSQx4HXrz09TyOOOn1osjeLIwW8wkMHK9Mnuc9fQ/n1+op8reXh8nYF2bj29Bn07ep6eopi7lDBdwCkqqquMHkDA69Tn64xwabLMSoCkbTgAh8gc9cHGew7dyTStdg9WLuZpV2jJIxk885OOD9MH6dfV5KkZTIIGevJHPHTkf555qFEw4G0bQNoVfm28Zx/nr+IqZPM84BFIdemDkDPc/z9/btexlLsi9orbdWjXHADEZIGTjlgenpz7fSuqVjglsYHHt/n1rltDAbUTjG0KwC88jBwB6fxf09a6ZVC7iOBjgenrWtjza/xEwHzYz0OSDyB70HGS2QDj8uv50xCNwK46jAH+frQWGMjn3J6UjCwoHygAHAGcDv+A/zzTs8E9scleh6009h6Y9v8nFC5PIOTk9O3/wBb3oGKdpG3Ix0/z6mmqfu9B2ODnI/z3pwwAoO44x75/wDrmghsHJAz3piEBBwQMemPwrktWX/S58tn525YHI2gcj2HHHr3611ZOMhgT3IPP+f8+vPHamS95MD98MX55HHQY7cDIJznnp0pM6KC94YQqyAYwW2lc/3SMk8d8gfn+bFILFyBtZRn5+cf73cgYGeP8WygMxOVw2NhK43Hn3zu7emR69WyN5qOVByG4b+I546cDPr9Mdqxeh6EERM4Ksy/xDOcYOSPyzjqR9eucMUHeSpwVAk3AEcY68+hPv271OAx27v9/BbkgjAJ9O3t0HTJpp/1n7vAyNwZOOnTPpz3z3+pqLbHREdblYyw4OVACg9B6Z+n06Ac8VqGZfL5G/vk8evzD06+vGM981mOobIxuYnBjx7DqOg9yPU9asW7nyl3NucDLYBUE47d/b/E5FUtFcmcU9SeFtzA/K2W2pjA4+nTPf8AKpAwwoJO0ADAJHXoR6/T/wDXUMZcliwyR8owOo7D/Pb1qcDcMAYH3Qw9ee35++D+Ra5lJCvcYXbjGSR3wPbA7c/y9OK7TZcBQoG3hcdD0xx254xnpj6vK7mySoA4GeDxxgen48jP4U2KBXkUfOCxwwzngHt7/wD18d6peY0orUtxO+4NvBUDLMuePz+n6fQU6Ply2F5IyOmOeR1x/nmrEcGxFZsZHJBOSfYe/HSiIqHA+UsGxx9Tn+Q/Ac02jnck72J0VvLPXI7+mR/n/PFStHIcgKMDIK57fj09fz60RKu1cZ9sj3/nkVJuAU5wFwCV6/pVHM5O+hTlVihJJZvx5H+elVpLUkMEIIAwD/njP+RnFXpmLBs5znLLjr7j/PpTAxyVcAE+nHfGf8/SkzWMmtjNaQoGEikkAcHnvnGPT/6/rULyhi3U5HpjcOp+vf1q3eQ79/y8t2A7H8fUH6VSkjO5/lZS4JyMde5PbuP8OlSzphZ6iM2SN7EA5B6Y9/rj/Hmp042gkAjq3Vs/T1+nuPWq5yhDA+XgYfB6ehyeo9j6e1KSy4+9tXll3Fsg9/cfT8OppMtq5HduN5I2rt+bYzAADHUd+P5VWgZ/OTy8ruOAEGencjOOMde2MU8OwcnAA++dwOCSevTnsMnqPfinRKSBwGbsT/H06+uCM+mPXdil5miVlYe0QPl7UG0LjBHQEnj0HY5we/bFQSxkY2rtOc8/w9jznk5Pbg59qtYDhcbiBk7uTjgjOQM45HT8c0iMd+CWK5O4jp07jv07dqZmpNFXakYXChQ45xwAOuO/OT+Oe+KbIuAQy7QTgj8OQCe/QEH/APVMInUDkiTAO7Jbg8Zx6c470FdnyxjoMkgZ6c/Q4znPtTiyWy9oBDamhBDEqxPtwR19MYwPfHGK6dd2TnnnHWuf8NQj7Qz/AC7VjbO0E4Jb39c10SjA4OD045x9P6VstNDza7vMYSdx6k5PBGM//q44/n1pxICk5HUY52/l+FO24BAIHfPYdeff2pTghsAd+QRxzQZCNkDIH4gge39MUvU85BB+mfSlAAC4B4HQ9fb8+nNNbGQBjDDPPf8AznH49qBbiFsY4AJPGe5zx/8Aq+v1oONpKhc4xg/5/wA4p55xz6Z/x/z/AEphBAAyB2Hb34H5YoGRPxnbyc4OOP5/5wfauU1Fs3VwW+YHId+cKuef8/0IrrZVLKcA7s8+xJ/z/SuRviWuwynlGG1iRkA9CM9c8YxjvmjobUfiKT7vLkZlOWYqeeQMYGD16L9evB7xgjbkiPH3lHXJ4zg9j/TtU4A+QjgAbB645BXPXBx+GD9KruM5YsATuIbP3hn19xjgf7P1rFtnp09SSFkLBt7AP8v9Tk/n3556VMXR2BD4Zjs3FiOuO3rz7dagSMgsZCG3Nj1YA9Fz0JwO1P2EYjwSzY+Yk8ZPUds+3Tt60k9DXQkBRjt3kHoB0I559s8Y+gJx1q7DCXRiuCMZX5eoJJ/r+meORVKOJmY7VLYAJGcY54wRyPb68VuW5RE8t9rY4POfr0zgH2//AFnQyqytsZvliOQFnAHKqS3bOcnP5544z+Ck4WMYwpyFVkJywyTx68ngf41JeSoZSQpAXJwTgA45/DPc9t3XioQwYAo42uvJPVv5nqc/1xQ7DV2rsGdiByOT8xIBJ69e2eo9+nvU+mZEu5GI+Ynn5vYgn/J44qq7EN8u45BJwM5GCOPrj1HWrmmyxoRvOQWwCPlz7/XqOewprZsU/hdi5POYyI8ENg5AOcfT1GaWCMOpYgbOp+nJ/THTpx+NU7hg0ic/MTjoVPH68cD3/Gr9vcxxqvIypwuOM++P8/yxVjmknGOhfhTy0wxG4k9Dnnof5U2VuSEBODwP6/r2/Sq896nlgg4GSSfu9ufyx9eO3Wq/2tMMWORjGQST6nr+HPvR5GCpyerLpUNGcDK564ye/J4/lVd9okbaAACcnk55xk/579+KY1y2CduM85boB/nv601Sskjbhk4zk84B4zn/AA9vWkWoNbkzfMpK9sY39yfXH09uue/EE0SFHU4AK8ZODj1P45PsakecENnedoyCOoB6/jk/zPNQtKR8pbnkYH8X1z6/174pXLiminMGWR25DgFsjHf+Ienpj6ds1XlxtOGRFBzwOAe5/Ac/gKtylWLZxj7xwcdffr+P1zVSUOgcgsr53HA5BHP9fc+lT0OmJSKhWV1AXeuRtUMCRxjt0Pf39eBIhGwDGV7nGCPwz6/THI7YDGc5PDbiMMwORzxnjr257cUyPIkPIDKOe5Gce3I9/wCmadjfoW1OWBwq7s52jPJOeD/+r9KcCGXdzk4AyPb8+cn8ulRhirdCVJAfJBBHOckdf60qA5KLkbW7jGPXH5cdecDrUpXMmiUHK5YNg5IwAcfj0Pbjnr7ioZCoVTIdojxuO4YXryef1B/wqY4Cg8bm5GF69MZ/Lp7k9c1WkJMgYAt1YYPJJ4P6/hg9RVrUxOk8PAeXcPgqCduG4x1JGD/nvxxWs3B59M/5/wA/n3zNCQx6cgIPLNjPfHTH8uPyrRwM4HAGP8P6/pWyPNm7ybHk4OT2ySccD8cf/X60AcjhuO3XH09+3/6qRcleCQc4z/8AWpOgfnP9Px7UEkmcgFeCOfp7Z/SmlMbuO+SMDg/570uMshPzc5B700AlUz95eRgA/X8qEIVDyM8cgdeh7j/9VIc7Ceo6Nn+v+cUKDkbQBkdfy/z/AE70gO3ptU+p9P8AP+elAwkGEYjC7c8gdq4nUFLmbaVDPxuZemeMZzz3x0Bz2ya7O6bbFIWXgBs9env37n9K4ubcZckhz94KRnnnqegPII7Umb4f4iOcjO6Ndrk7R3zn37cf16CoVbLHAwN2XJUkjI4J7evPofY1ZYEAPnB2ncxzu6/yx1Off6RJC+7OVUqd5+bKg9iSP4f8OO+cWelT2JLeLgSE8DB7AgeuM98E/hmpNhBMYV9wBA6+oOcjnGc+38qWMMvHzb1/u4yvv7Z9OmBUcuCpMhjGfmJJO3kgbueSOg56gn3qb30K3ZJE2w5U8PgKCOmfYfUce3PepXeR43KuxGAFBPXpj9cjnP8APEEJ24bAAI4XByOgBP5ZBwM+1XGn2xAfNweuM5xwM+mKpdxS3K0tuWDFBgjORyeeO/0xkj2qPc6YY8lSSORz3zkdjj06YxipnlEmVVSwPBBG7K5wevXHPqeajIeXG4ne4GcHOT6jnj0+v1xRuik3bUQS7olz95iSobK55xwOvUd6Ym/zMAbfvKozk7e4/A45689uKesW5yCoKvngn7w59ux5/P3rStbXHXBUAZ4GT/8AW7f5NPzCc1ApxI7kKcc8YVs8Z6ZP+TjsauWkKudxLEnI6nJ4PXPOPx6GhV2OQ21h3GThhwce4J7devFOw7SbYzgk4B4z7t74/wD10GEpX2F8hdxUE7QcKoxkeg/+scevSoZ4UiClQoAX7xJBznI57fhnr+FPcSxkSPnbkg7v7pPOR3PXPXniq8txI2d3DAE5lxgH09fb+fam3qON3rcsW5B+XBDdyAcA9/zz+PJq4IlL9TnPAx69P1xz71kqHjBKAjaeAzAYI4x3+nPHHapWeYbwwYfQ4/pz3qegpU23ozVmt4nhY5ONu0Y9P/rY+nSsuXIl2vxnIK57+xPXtyf5dHG8lRW3kYx7DI9/wx+mfZrSrubDKXx+YPTk/wCQfrQ7ihCUd9RMHafMADADKFR3PH/6+3fNQyqxUqpUN1GR0PoVJ6f4Z71IsxTg/wAPHA5X3x0xnr749TUcuz5TyOASd3556emAf5YzRboaq9yiwJBGARwT8uGbsPzAOfw+tLEg2gJyAN2VwAOvQ49+h4yfc04EqwVzyGxjIGAe3qc9z604lcAhcYHQ8dMdBnpzk8/1NI1bGS5LlZMBuck/Lj1Ht9Ow46chDIyldgyBjJB6dgxHrgj6YwabMRgKMEIcjd/DgZ5wOPXPf86ijkU4AyNzEjf94k5xk889f85qtybFzeY42J3IeQcdQQR0PUHj3/xZGSsiLtPl59fTOeOnYjNIv90jJ2bdocjI6EY/TjpkZqRVO9yCCXIBJ5OcYGfXiqiuphM66wQxWEKhcMU3cgnB7ZP5VZIIzjPXnt2/KmxR7I41OflUA59duP8APP8ASnbcMNobK98e/H+fatNzym7u47sGAJ7fUdv0P0/SmuPlPBwOQFxjHP4elKuOSoHynA54/wD1cfn1oKnJ2dM/56UAPHIBJ5PJwQevf6UpGTg9en0/z/n1oPGMDk9e3/6u1IT8noB6dOv+fzoEIRkDrg/p9KQkEnPU8nj+n+fxpRnnqCeeM9fb/D/A0cgg8A9gOnt/nHNAFbUCVtJcZX5Thic8+v69a4p9rh3K7k688rgnGccgfj7112tsY7BmAU4YfePGNw6/z+o9K5BR80wIZhkAs3UAdRz3/Hv2yaTOrDkx/wBbsUlXwAdxPPJweepzjp6+tPhXewZdpAzwfy4P9cc9utV5yxmcknBY9OevDH2747jPpxU9uAVXaTtAY4GRx6Z7Ht3x61id6VlcbtC52g4xkADAB4H4gdOh7UKmWA+YMCeVboSOOfz9fxzipZYVLJkAcZJIHHbjrz24+lRzHYpYxkDAOCwAA6E569f1NToWnccYCjBwyZ2gtnjpjnp0OQSM96bMznkA5Ckkjnn27DBx+lJ58oDBvvcZbBwD29/z96T7UZhko2OSwA3ADPOPUd/8OlVdlJSEjJKhWAAxk7ScAdj/AJ9R3HNhMAjG4kZ+UDqP5jHrVW3TBG5BlScrs9sE/oc/n71djU7fmbGRkhgGIwMj9OM9znFJinoSWyEBAR8x+UlMYx2Hfpk1aYtwUPlkHJxxj39v896LUJu3fdyCTkDpzn9cnHHSp5dqKgA24XHB6ep/z/hVXOWcryKTb944wwGcY98dP0/EU5cxSZwVGQQMA89PyHT/AB7PkVY1x91RwcnAyeP64/GkBHl4AUnquQAMep+h9vT2pbjvcdO+6MgYJB6D9f5Z/qKplMEKzbFJyBjGRz7dO/c1qCNFUMADt5weBjPb0+n156YpXEioSiEAdSpAwffJ79Rg/wA8VWgQl0Qi7hwxO7GduBwxBAx3Gfx/DnMbbQHXC7enXpz+PscZHXNPSRWVhwFK/wAY6JxjIPTPHpj2FNZ8ExjOdoyCTn6EevGT+XtQmaK9yvcMR5mQFyvzKBgnB7enXP61GWYBgVbcMlgAWB/Pr1/Hj6h7oSrODgdSQoPU9fX0HY/gaVod4+cDHr1GPbnP6/kek6dTVNJAPlKjOCMEDnt04+vc8nNQzuE2scncMHd/j3/Hk/UVNJ/GW3buuCSCMngcfqeh/HitIGJJ4/uBgoCgc5AHbgjj/wCtTew4q71IY5Cx2oSBt42uRk8bTx04GM/j06JI2ZQRglvnOFIAGRxj+hxzj1oSEMq+WFydxULgFec7Tk4POTk/p0LnQkBRyrNjeDgk/UcjGefwHOaTL0uHllHUYclTypYBsDkEZ5I6/wCTmo4YwHYAoqMcFt/UE5z3yBjOP8KkWTJypUDbyrcFeSQAR+o69D65kdMRgNwQNqg9Wx6H2xg/4Uk/MhvoIxI2/KydSARjrnt1Axn06+3FrT0D30Sr5hJdflGeec8e3+NV0i+QDHQkk46c5xn1POD69jzV/wAPAvqceQvUFuOvHU8ceuPr+G0WclZ+62dbk5JBOQeg59e34mnAckZ4BPIzn0/GlHQYJwBxn0phJHA25BHLccZ5/Tp29etUeYI+Wzg8ngf/AFv6UpLbmB9ufTr36elOYZ+XdkFiMf57VGMYbjjqcH9PegEf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H. Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Multiple areas of capillary loop dilatation in a patient with dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John H. Stone, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23573=[""].join("\n");
var outline_f23_1_23573=null;
var title_f23_1_23574="Recombinant human factor VIII: Drug information";
var content_f23_1_23574=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Recombinant human factor VIII: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?21/32/22020?source=see_link\">",
"    see \"Recombinant human factor VIII: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/11/33975?source=see_link\">",
"    see \"Recombinant human factor VIII: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F135784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Advate;",
"     </li>",
"     <li>",
"      Helixate&reg; FS;",
"     </li>",
"     <li>",
"      Kogenate&reg; FS;",
"     </li>",
"     <li>",
"      Recombinate;",
"     </li>",
"     <li>",
"      Xyntha&reg;;",
"     </li>",
"     <li>",
"      Xyntha&reg; Solofuse&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F135785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Advate;",
"     </li>",
"     <li>",
"      Helixate&reg; FS;",
"     </li>",
"     <li>",
"      Kogenate&reg; FS;",
"     </li>",
"     <li>",
"      Xyntha&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F135799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antihemophilic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F135786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hemophilia A:",
"     </b>",
"     I.V.: Individualize dosage based on coagulation studies performed prior to treatment and at regular intervals during treatment. In general, administration of factor VIII 1 unit/kg will increase circulating factor VIII levels by ~2 units/dL. (General guidelines presented; consult individual product labeling for specific dosing recommendations.)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Dosage based on desired factor VIII increase (%):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     To calculate dosage needed based on desired factor VIII increase (%):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     [Body weight (kg) x desired factor VIII increase (%)] divided by 2(%/units/kg)  = units factor VIII required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     For example:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     50 kg x 30 (% increase) divided by 2  = 750 units factor VIII",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Dosage based on expected factor VIII increase (%):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     It is also possible to calculate the",
"     <b>",
"      expected",
"     </b>",
"     % factor VIII increase:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     [# units administered x 2(%/units/kg)] divided by body weight (kg) = expected % factor VIII increase",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     For example:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     [1400 units x 2] divided by 70 kg = 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      General guidelines (consult individual product labeling for specific dosage recommendations):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Minor hemorrhage: 10-20 units/kg as a single dose to achieve FVIII plasma level ~20% to 40% of normal. Mild superficial or early hemorrhages may respond to a single dose; may repeat dose every 12-24 hours for 1-3 days until bleeding is resolved or healing achieved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Moderate hemorrhage/minor surgery: 15-30 units/kg to achieve FVIII plasma level 30% to 60% of normal. May repeat 1 dose at 12-24 hours if needed. Some products suggest continuing for &ge;3 days until pain and disability are resolved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Major to life-threatening hemorrhage: Initial dose 30-50 units/kg followed by a maintenance dose of 20-50 units/kg every 8-24 hours until threat is resolved, to achieve FVIII plasma level 60% to 100% of normal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Minor surgery (including tooth extraction): 15-50 units/kg to raise factor VIII level to ~30-100% before procedure/surgery. May repeat every 12-24 hours until bleeding is resolved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Major surgery: 40-60 units/kg given preoperatively to raise factor VIII level to ~60% to 120% before surgery begins. May repeat as necessary after 6-24 hours until wound  healing. Intensity of therapy may depend on type of surgery and postoperative regimen.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If bleeding is not controlled with adequate dose, test for presence of inhibitor. It may not be possible or practical to control bleeding if inhibitor titers &gt;10 Bethesda units/mL.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Routine prophylaxis to prevent bleeding episodes (Advate):",
"     </i>",
"     20-40 units/kg every other day (3-4 times weekly). Alternatively, an every-third-day dosing regimen may be used to target factor VIII trough levels of &ge;1%.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F135795\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/11/33975?source=see_link\">",
"      see \"Recombinant human factor VIII: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hemophilia A:",
"     </b>",
"     I.V.: Refer to adult dosing.",
"     <b>",
"      Note:",
"     </b>",
"     Children &lt;6 years may require more frequent administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Routine prophylaxis to prevent bleeding episodes (Advate):",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Routine prophylaxis to prevent bleeding episodes and joint damage (without pre-existing joint damage) (Helixate&reg; FS, Kogenate&reg; FS):",
"     </i>",
"     25 units/kg every other day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F135787\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15673189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15673190\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F135770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Advate: 250 units, 500 units, 1000 units, 1500 units, 2000 units, 3000 units, 4000 units [plasma/albumin free; contains mannitol, polysorbate 80, sodium; derived from or manufactured using hamster or mouse protein; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Helixate&reg; FS: 250 units, 500 units, 1000 units [contains polysorbate 80, sodium, sucrose 28 mg/vial; derived from or manufactured using hamster or mouse protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Helixate&reg; FS: 2000 units, 3000 units [contains polysorbate 80, sodium, sucrose 52 mg/vial; derived from or manufactured using hamster or mouse protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kogenate&reg; FS: 250 units, 500 units, 1000 units [contains polysorbate 80, sodium, sucrose 28 mg/vial; derived from or manufactured using hamster or mouse protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kogenate&reg; FS: 2000 units, 3000 units [contains polysorbate 80, sodium, sucrose 52 mg/vial; derived from or manufactured using hamster or mouse protein]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Recombinate: 250 units, 500 units, 1000 units, 1500 units, 2000 units [contains albumin (human), natural rubber/natural latex in packaging, polysorbate 80, sodium; derived from or manufactured using bovine, hamster or mouse protein; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyntha&reg;: 250 units, 500 units, 1000 units, 2000 units [albumin free; contains polysorbate 80, sucrose; derived from or manufactured using hamster  protein; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xyntha&reg; Solofuse&trade;: 1000 units, 2000 units, 3000 units [albumin free; contains polysorbate 80, sucrose; derived from or manufactured using hamster protein; dual-chamber syringe]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F135756\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F135773\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use administration sets/tubing provided by manufacturer (if provided).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Advate: Infuse over &le;5 minutes (maximum: 10 mL/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Helixate&reg; FS, Kogenate&reg; FS: Infuse over 1-15 minutes; based on patient tolerability",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recombinate reconstituted with 5 mL of SWFI: Infuse at a rate of &le;5 mL/minute (maximum: 5 mL/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Recombinate reconstituted with 10 mL of SWFI: Infuse at a rate of &le;10 mL/minute (maximum: 10 mL/minute)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Xyntha&reg;, Xyntha&reg; Solufuse&trade;: Infuse over several minutes; adjust based on patient comfort. Do not admix or administer in same tubing as other medications.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F135772\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of hemorrhagic episodes in patients with hemophilia A (classic hemophilia or congenital factor VIII deficiency); perioperative management of hemophilia A; routine prophylaxis in patients with hemophilia A to prevent bleeding episodes (Advate, Helixate&reg; FS, Kogenate&reg; FS)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Helixate&reg; FS and Kogenate&reg; FS are also approved in children with hemophilia A with no pre-existing joint damage to reduce risk of joint damage. In addition, Recombinate can be of therapeutic value in patients with acquired factor VIII inhibitors &le;10 Bethesda units/mL.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6814324\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Factor VIII may be confused with Factor XIII",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Confusion may occur due to the omitting of  &ldquo;Factor VIII&rdquo; from some product labeling. Review product contents carefully prior to dispensing any antihemophilic factor.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F135798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Actual frequency may vary by product.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;1%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Chills, dizziness, fever, headache, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Constipation, diarrhea, nausea, taste perversion, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection/infusion site reactions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, joint swelling, pain in extremity, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Ear infection, ear pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, nasal congestion, nasopharyngitis, pharyngolaryngeal pain, rhinorrhea, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Catheter thrombosis, catheter infection, factor VIII inhibitor formation, flu-like syndrome, influenza",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &le;1% (Limited to important or life-threatening): Abdominal pain, adenopathy, allergic reactions, anaphylaxis, anemia, angioedema, anorexia, arthralgia, AST increased, chest discomfort, chest pain,  cyanosis, depersonalization, diaphoresis, dyspnea, edema, epistaxis, erythema, facial edema, facial flushing, factor VIII decreased, fatigue, GI hemorrhage, hematoma, hives, hot flashes, hyperhidrosis, hypersensitivity reaction, hyper-/hypotension (slight), infection, laryngeal edema, lethargy, malaise, pallor, paresthesia, restlessness, rhinitis, rigors, shortness of breath, somnolence, tachycardia, tremor, urinary tract infection, vasodilation, venous catheter access complications",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F135776\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F135760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Antibody formation: The development of factor VIII antibodies has been reported with antihemophilic factors; monitor for signs of formation of antibodies to factor VIII; may occur at anytime but more common in young children with severe hemophilia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypersensitivity reactions: Allergic hypersensitivity reactions (including anaphylaxis) may occur; monitor.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Albumin: Recombinate is stabilized using human albumin.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bovine: Recombinate may contain bovine protein.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mouse/hamster protein:  Advate, Helixate&reg; FS, Kogenate&reg; FS,  Recombinate, and Xyntha&reg;  may contain trace amounts of mouse or hamster protein.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Polysorbate 80: Some products may contain polysorbate 80.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sucrose: Helixate&reg; FS and Kogenate&reg; FS are stabilized with sucrose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; von Willebrand factor: Products contain naturally-occurring von Willebrand factor for stabilization; however, efficacy has not been established for the treatment of von Willebrand disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dose requirements: The dosage requirement will vary in patients with factor VIII inhibitors; optimal treatment should be determined by clinical response.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6218001\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F135766\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F135778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Safety and efficacy in pregnant women has not been established. Use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F135791\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F3000257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Helixate FS Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 unit (1): $1.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 unit (1): $1.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3000 unit (1): $1.56",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Kogenate FS Bio-Set Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Kogenate FS Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Xyntha Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Kit",
"     </b>",
"     (Xyntha Solofuse Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3000 unit (1): $1.66",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Advate Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1500 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4000 unit (1): $1.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Recombinate Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     220-400 unit (1): $1.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     401-800 unit (1): $1.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     801-1240 unit (1): $1.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1241-1800 unit (1): $1.63",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1801-2400 unit (1): $1.63",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F135768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Heart rate and blood pressure (before and during I.V. administration); plasma factor VIII activity prior to and during treatment; development of factor VIII inhibitors; signs of bleeding; hemoglobin, hematocrit",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F135771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Classification of hemophilia; normal is defined as 1 unit/mL of factor VIII",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Severe: Factor level &lt;1% of normal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Moderate: Factor level 1% to 5% of normal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mild: Factor level &gt;5% to &lt;40% of normal",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F135779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Advate (AU, GB, IE, NZ);",
"     </li>",
"     <li>",
"      Alphanate (HK, MY, PH, SG, TH);",
"     </li>",
"     <li>",
"      Bayer Koate-HP (PH);",
"     </li>",
"     <li>",
"      Beriate HS (DE);",
"     </li>",
"     <li>",
"      Beriate hs (HN);",
"     </li>",
"     <li>",
"      Beriate-p (TW);",
"     </li>",
"     <li>",
"      Cutter Koate-HP (TW);",
"     </li>",
"     <li>",
"      Emoclot DI (IN);",
"     </li>",
"     <li>",
"      Fandhi (IL);",
"     </li>",
"     <li>",
"      Green Eight (KP);",
"     </li>",
"     <li>",
"      Haemate (DK, SE);",
"     </li>",
"     <li>",
"      Haemate HS (CH, DE);",
"     </li>",
"     <li>",
"      Haemate P (IL, TW);",
"     </li>",
"     <li>",
"      Haemate-P (IT, NL);",
"     </li>",
"     <li>",
"      Haemoctin SDH (SG);",
"     </li>",
"     <li>",
"      Haemosolvate Factor VIII (ZA);",
"     </li>",
"     <li>",
"      Helixate NexGen (GB, IE);",
"     </li>",
"     <li>",
"      Hemofil M (DE, IT, PH, TW);",
"     </li>",
"     <li>",
"      Hyate C (TW);",
"     </li>",
"     <li>",
"      Koate DVI (AR, CN, CO, CR, DO, GT, ID, MX, PA, SV);",
"     </li>",
"     <li>",
"      Koate HP (PK);",
"     </li>",
"     <li>",
"      Koate hs (IT);",
"     </li>",
"     <li>",
"      Koate-DVI (HK, IL, PH, UY);",
"     </li>",
"     <li>",
"      Koate-hp (GR);",
"     </li>",
"     <li>",
"      Koate-HP (PY);",
"     </li>",
"     <li>",
"      Kogenate (FR, IE, IL, NZ, TW);",
"     </li>",
"     <li>",
"      Kogenate FS (AU, SG, TH);",
"     </li>",
"     <li>",
"      Kryobulin TIM 3 (CZ, HN);",
"     </li>",
"     <li>",
"      Monarc M (IL);",
"     </li>",
"     <li>",
"      Monoclate-P (AT, FR, GB, IE, KP, TW);",
"     </li>",
"     <li>",
"      Monoclate-p (DK, GR, SE);",
"     </li>",
"     <li>",
"      Nordiocto (DK);",
"     </li>",
"     <li>",
"      Novo Nordsk (MX);",
"     </li>",
"     <li>",
"      Novoseven (MX);",
"     </li>",
"     <li>",
"      Octonativ-M (SE);",
"     </li>",
"     <li>",
"      Profilate (DE);",
"     </li>",
"     <li>",
"      Profilate OSD (TW);",
"     </li>",
"     <li>",
"      Profilate SD (HK, ID, PH);",
"     </li>",
"     <li>",
"      Recombinate (AU, DE, DK, FR, GB, IE, NZ, TH);",
"     </li>",
"     <li>",
"      Refacto (GB, IE);",
"     </li>",
"     <li>",
"      Ristofact (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F135759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Factor VIII replacement, necessary for clot formation and maintenance of hemostasis. It activates factor X in conjunction with activated factor IX; activated factor X converts prothrombin to thrombin, which converts fibrinogen to fibrin, and with factor XIII forms a stable clot.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F135775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      ss",
"     </sub>",
"     : ~0.4 dL/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Mean: ~11-15 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Lusher JM, &ldquo;Transfusion Therapy in Congenital Coagulopathies,&rdquo;",
"      <i>",
"       Hematol Oncol Clin North Am",
"      </i>",
"      , 1994, 8(6):1167-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/1/23574/abstract-text/7860443/pubmed\" id=\"7860443\" target=\"_blank\">",
"        7860443",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Manucci PM, &ldquo;Impact of Recombinant Factor VIII on Hemophilia Care,&rdquo;",
"      <i>",
"       Vox Sang",
"      </i>",
"      , 1994, 67(Suppl 3):49-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/1/23574/abstract-text/7975511/pubmed\" id=\"7975511\" target=\"_blank\">",
"        7975511",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nilsson IM, Berntorp E, Lofqvist T, et al, &ldquo;Twenty-five Years' Experience of Prophylactic Treatment in Severe Haemophilia A and B,&rdquo;",
"      <i>",
"       J Intern Med",
"      </i>",
"      , 1992, 232(1):25-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/1/23574/abstract-text/1640190/pubmed\" id=\"1640190\" target=\"_blank\">",
"        1640190",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      White GC, Rosendaal F, Aledort LM, et al, &ldquo;Definitions in Hemophilia. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis,&rdquo;",
"      <i>",
"       Thromb Haemost",
"      </i>",
"      , 2001, 85(3):560.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/1/23574/abstract-text/11307831/pubmed\" id=\"11307831\" target=\"_blank\">",
"        11307831",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9723 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23574=[""].join("\n");
var outline_f23_1_23574=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135784\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135785\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135799\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135786\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135795\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135787\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15673189\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15673190\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135770\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135756\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135773\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135772\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6814324\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135798\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135776\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135760\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298758\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6218001\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135766\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135778\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135791\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3000257\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322993\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135768\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135771\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135779\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135759\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F135775\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9723\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9723|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?21/32/22020?source=related_link\">",
"      Recombinant human factor VIII: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/11/33975?source=related_link\">",
"      Recombinant human factor VIII: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_1_23575="Amelanotic melanoma 2";
var content_f23_1_23575=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62791%7EDERM%2F51998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62791%7EDERM%2F51998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amelanotic melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amelanotic melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23575=[""].join("\n");
var outline_f23_1_23575=null;
var title_f23_1_23576="Arrhythmias following cardiac transplantation";
var content_f23_1_23576=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Arrhythmias following cardiac transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Howard J Eisen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Luke S Kusmirek, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Sharon A Hunt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Leonard I Ganz, MD, FHRS, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23576/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/1/23576/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac arrhythmias are common in the orthotopic heart transplant recipient, particularly in the early postoperative period. Premature atrial complexes and premature ventricular complexes are especially frequent, with a reported incidence of over 60 percent. Fortunately, these arrhythmias have little clinical importance. However, other cardiac arrhythmia, such as sinus node dysfunction and ventricular tachycardia, may result in significant morbidity or mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24872074\">",
"    <span class=\"h1\">",
"     MECHANISMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several mechanisms for arrhythmogenesis in the transplanted heart, with early postoperative arrhythmia resulting from different mechanisms than those occurring later. Surgical trauma to the sinoatrial and atrioventricular nodes, ischemia during preservation, surgical suture lines, and, over the long-term, rejection and accelerated atherosclerosis may contribute to the formation of an arrhythmogenic substrate. As an example, one autopsy study of 18 hearts found that acute rejection involved the conduction system as severely as the myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/1\">",
"     1",
"    </a>",
"    ]. With chronic rejection, there was obstructive vasculopathy of the sinus node artery.",
"   </p>",
"   <p>",
"    In occasional cases, severe rejection isolated to the conduction system with sparing of the rest of the myocardium occurs and presents as bradycardia with syncope [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, the denervated donor heart has increased sensitivity to sympathetic amines, adenosine, and acetylcholine, which may contribute to both tachyarrhythmias and bradyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The sympathetic effect may be presynaptic in origin; it is not due to increased beta receptor density [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SINUS RATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the denervated heart, the normal resting sinus rate is usually greater than 80 bpm and may exceed 100 bpm in hearts transplanted from young donors. The heart rate is higher than in normals because of the loss of vagal neural inputs which have a negative chronotropic effect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/25/14742?source=see_link\">",
"     \"Sinus tachycardia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Partial reinnervation of cardiac sympathetic nerves after transplantation occurs in about one-third of patients at one year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. The process of reinnervation continues gradually for up to 15 years but is regionally heterogeneous [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Reinnervation of the sinus node is accompanied by partial restoration of the normal heart rate response to exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vagal innervation appears to be absent in the majority of patients for up to 96 months after transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/11\">",
"     11",
"    </a>",
"    ]. Vagal reinnervation may depend upon surgical technique; it occurs more commonly with bicaval compared to standard surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/12\">",
"     12",
"    </a>",
"    ]. Standard surgery cuts about 50 percent of sympathetic fibers, but most recipient vagus nerve trunks remain intact. As a result, there is a stimulus for sympathetic fiber, but not vagal fiber, regeneration. In contrast, bicaval surgery cuts both sympathetic and parasympathetic fibers and regeneration may be stimulated in both branches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SINUS NODE DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus node dysfunction, which may be manifested by a relative bradycardia, occurs in up to 50 percent of patients in the first several weeks following transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Although this early abnormality does not appear to affect mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/16\">",
"     16",
"    </a>",
"    ], sinus bradycardia may result in significant morbidity from decreased cardiac output, and as many as 16 percent of these patients require a permanent pacemaker [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/17\">",
"     17",
"    </a>",
"    ]. In a retrospective series of 556 heart transplant recipients, 41 (7.4 percent) required a permanent pacemaker for sinus bradycardia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/18\">",
"     18",
"    </a>",
"    ]. Intact atrioventricular nodal function is usually present; thus, atrial pacing is used and only a single atrial lead is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/19\">",
"     19",
"    </a>",
"    ]. Lead dislodgement during endomyocardial biopsy does not occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Potential causes of sinus node dysfunction include ischemia during hypothermic preservation; surgical trauma to the sinus node, perinodal atrial tissue, or sinoatrial artery; pretransplant use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ; and immunologic processes such as rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/15,20\">",
"     15,20",
"    </a>",
"    ]. In one series, for example, patients who required permanent pacemakers for sinus bradycardia had a significantly higher prevalence of abnormal sinoatrial nodal arteries when compared to a control group of heart transplant recipients with normal sinus node function [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several studies have suggested a correlation with the donor ischemic time [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/14,17,21\">",
"     14,17,21",
"    </a>",
"    ]; however, in one large series, the donor ischemic time was not significantly different in 41 of 556 orthotopic heart transplant recipients who required implantation of a permanent pacemaker for sinus bradycardia compared to those without this complication [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical trauma to the sinoatrial artery can be avoided by performing a bicaval anastomosis rather than the standard atrial anastomosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]; this has become the most commonly used procedure in transplant centers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/24\">",
"     24",
"    </a>",
"    ]. This technique consists of total excision of the right atrium with a minimum cuff or left atrium remaining around the four pulmonary veins, followed by direct anastomoses on the vena cavae. It appears to be associated with a decreased incidence of sinus node dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. In a prospective series of 70 orthotopic heart transplant recipients undergoing either an atrial or bicaval anastomosis, the incidence of sinus node dysfunction, as determined by atrial pacing techniques, was much lower with bicaval anastomosis (5 versus 44 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/27\">",
"     27",
"    </a>",
"    ]. This finding was confirmed in a United Network for Organ",
"    <span class=\"nowrap\">",
"     Sharing/Organ",
"    </span>",
"    Procurement and Transplantation Network",
"    <span class=\"nowrap\">",
"     (UNOS/OPTN)",
"    </span>",
"    database analysis of 20,999 recipients indicating that those transplanted utilizing bicaval anastomosis had lesser need for pacemaker therapy and improved long-term survival [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A separate",
"    <span class=\"nowrap\">",
"     UNOS/OPTN",
"    </span>",
"    database analysis of 35,987 patients reported a 10.9 percent incidence of pacemaker-requiring bradyarrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/29\">",
"     29",
"    </a>",
"    ]. A biatrial anastomosis as well as greater recipient and donor age were the only factors associated with increased permanent pacemaker requirement. Pacemaker implantation had no adverse effect on survival; in fact, survival was better in pacemaker recipients as compared to those not receiving a pacemaker.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28084306\">",
"    <span class=\"h2\">",
"     Treatment of sinus bradycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normalization of post-transplant sinus node dysfunction and bradyarrhythmias occurs in up to 55 percent of patients during the first three postoperative months and a conservative strategy is reasonable in the early postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The administration of either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/30,31\">",
"     30,31",
"    </a>",
"    ] or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/55/12151?source=see_link\">",
"     terbutaline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/32\">",
"     32",
"    </a>",
"    ] has been advocated to increase the sinus rate and avoid implantation of a permanent pacemaker during the first three post-operative months. Studies comparing the acute effects of these agents, however, have demonstrated only a modest shortening of the sinus node cycle length and recovery time, with incomplete correction of the underlying sinus node abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Thus, these drugs are probably best reserved for patients with only mild or moderate sinus node dysfunction or those with postoperative bradycardia due to prior",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    use.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    is not an effective treatment for bradycardia when vagal innervation is absent, so intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    is suggested in the unlikely event that treatment of bradycardia is needed in the heart transplant patient undergoing intercurrent surgery.",
"   </p>",
"   <p>",
"    Patients with more severe bradycardia that persists for more than two weeks after transplantation usually require a permanent pacemaker; a rate-responsive dual chamber or atrial pacemaker (if intact atrioventricular conduction is present) is recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=see_link\">",
"     \"Modes of cardiac pacing: Nomenclature and selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of biventricular pacing is not known in cardiac transplant recipients who fulfill the criteria used for such therapy in nontransplant patients. Successful implementation of cardiac resynchronization therapy in heart transplant patients has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONDUCTION DISTURBANCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common conduction abnormality following orthotopic heart transplant is a new right bundle branch delay not present on the donor ECG prior to transplantation. This can occur in up to 70 percent of patients and is usually manifested as an incomplete right bundle branch block [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/37\">",
"     37",
"    </a>",
"    ]. The conduction abnormality may persist and, in one study, was associated with prolonged donor ischemic time and multiple episodes of rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/38\">",
"     38",
"    </a>",
"    ]. Potential mechanisms for the right bundle branch block include right ventricular hypertrophy from elevated pulmonary pressures or damage to the right bundle from endomyocardial biopsy sampling of the right ventricular septal wall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10344?source=see_link\">",
"     \"Right bundle branch block\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the transplanted heart is denervated, atrioventricular (AV) nodal function is intact and the ability of the AV node to adapt to exercise with a shortening of the PR interval is retained since it remains sensitive to circulating catecholamines [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/39\">",
"     39",
"    </a>",
"    ]. High grade AV block is uncommon, particularly in the early postoperative period [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/14\">",
"     14",
"    </a>",
"    ]. Although pacemaker implantation is in as many as 16 percent of patients, AV block accounts for less than 10 percent of these cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/18,40,41\">",
"     18,40,41",
"    </a>",
"    ]. The late development of heart block has been associated with in an increase in mortality, often from transplant arteriopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/9/18585?source=see_link\">",
"     \"Natural history and diagnosis of cardiac allograft vasculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for pacemaker placement are the same as for other patients with one specific indication: symptomatic bradyarrhythmias or chronotropic incompetence that are not expected to resolve (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=see_link\">",
"     \"Indications for permanent cardiac pacing\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SUPRAVENTRICULAR ARRHYTHMIAS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Atrial premature beats",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isolated atrial premature beats (APBs) and nonsustained atrial dysrhythmias are common in the early postoperative period, occurring in up to 76 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/14,43,44\">",
"     14,43,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=see_link\">",
"     \"Supraventricular premature beats\"",
"    </a>",
"    .) The prevalence is lower at long-term follow-up, decreasing from 55 percent in the early post operative period to 30 percent at mean of 24 months after transplantation in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/43\">",
"     43",
"    </a>",
"    ]. There is conflicting data on whether APBs occur with increased frequency during episodes of rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Atrial fibrillation or flutter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reports of patients with atrial fibrillation (AF) or atrial flutter following cardiac transplantation have variably included perioperative and late arrhythmia. Atrial fibrillation has been described in 10 to 24 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/46-48\">",
"     46-48",
"    </a>",
"    ], while atrial flutter has been described in 12 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/44,48\">",
"     44,48",
"    </a>",
"    ]. These arrhythmias often occur in the absence of significant rejection, although this has not been found in all reports [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/44,46,47,49\">",
"     44,46,47,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most episodes of AF occur within the first 30 to 60 days after transplantation with incidence ranging from 5 to 11 percent in large, single center experiences. This relatively low rate, compared to typical post-pericardiectomy AF incidence is postulated to be due to surgical pulmonary vein isolation and cardiac denervation, which occurs with the heart transplantation surgery. Late AF develops in 5 to 10 percent of patients and is associated with the loss of the transplanted organ function and increased overall mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/46,48,50,51\">",
"     46,48,50,51",
"    </a>",
"    ]. Atrial flutter may be a more common late arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Atrial flutter that occurs in the absence of rejection is a result of a macroreentrant circuit in a counterclockwise direction around the tricuspid ring, similar to that seen in typical atrial flutter in normal hearts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/52-54\">",
"     52-54",
"    </a>",
"    ]. This circuit includes the isthmus between the tricuspid valve and the inferior vena cava, referred to as the cavotricuspid isthmus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/53/15192?source=see_link\">",
"     \"Electrocardiographic and electrophysiologic features of type I atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The cause of atrial dysrhythmias during rejection is not known. It is possible that the patchy nature of rejection results in heterogeneous impairment of atrial conduction and refractoriness, allowing for the formation of multiple microreentrant circuits. In addition, atrial hemodynamics may be altered by the reduced ventricular function and compliance that occur during rejection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=see_link\">",
"     \"The electrocardiogram in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of these arrhythmias includes control of the ventricular response rate and, if warranted, immunosuppressive therapy for rejection. Overdrive pacing can be performed at the time of myocardial biopsy with more than a 90 percent success in terminating atrial flutter [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are case reports and small series of successful radiofrequency ablation of atrial flutter in transplanted hearts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. Interestingly, the usual suture line between the donor and recipient heart lies within the cavo-tricuspid isthmus, which, as noted above, is a critical component of the circuit of typical atrial flutter. In a series of six cardiac transplant recipients undergoing EPS for atrial flutter, only the tissue below the suture line from the donor heart was part of the macroreentrant circuit. In all of these cases, ablation from the tricuspid annulus to the suture line, rather than all the way to the IVC, successfully eliminated atrial flutter [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/54\">",
"     54",
"    </a>",
"    ]. Macroreentry based on the gaps in the atrial anastomosis line and",
"    <span class=\"nowrap\">",
"     microreentrant/focal",
"    </span>",
"    atrial tachycardias successfully treated with radiofrequency ablation have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18201?source=see_link\">",
"     \"Restoration of sinus rhythm in atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Supraventricular tachycardias",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of supraventricular arrhythmias can occur in orthotopic heart transplant recipients, including atrioventricular (AV) reentrant tachycardia involving a concealed AV bypass tract [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/56-58\">",
"     56-58",
"    </a>",
"    ], Wolff-Parkinson-White syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/59,60\">",
"     59,60",
"    </a>",
"    ], and sustained atrial tachycardias [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/47,61\">",
"     47,61",
"    </a>",
"    ]. Radiofrequency catheter ablation has been performed in many of these of patients with success and complication rates similar to nontransplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/58,60,61\">",
"     58,60,61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15304?source=see_link\">",
"     \"Catheter ablation for AV nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     VENTRICULAR ARRHYTHMIAS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Ventricular premature beats and nonsustained ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular premature beats (VPBs) are common in the early posttransplant period, occurring in up to 100 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/14,44\">",
"     14,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=see_link\">",
"     \"Prevalence and evaluation of ventricular premature beats\"",
"    </a>",
"    .) The incidence of VPBs decreases after the early postoperative period and does not appear to be associated with rejection or other factors.",
"   </p>",
"   <p>",
"    The frequency of nonsustained ventricular tachycardia (NSVT) also decreases over time [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/43\">",
"     43",
"    </a>",
"    ]. However, some studies have demonstrated an association with both rejection and coronary atherosclerosis (cardiac allograft vasculopathy) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/14,62\">",
"     14,62",
"    </a>",
"    ]. In one small series, for example, complex ventricular ectopy (multifocal VPBs and couplets) occurring in the late transplant period was also more prevalent in patients with severe cardiac allograft vasculopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/9/18585?source=see_link\">",
"     \"Natural history and diagnosis of cardiac allograft vasculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Sustained ventricular arrhythmias and sudden cardiac death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sustained ventricular arrhythmias are uncommon in the donor heart; when they occur, they are usually associated with either severe transplant cardiac allograft vasculopathy or allograft rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/63\">",
"     63",
"    </a>",
"    ]. Ventricular fibrillation has been reported in patients hospitalized for severe allograft rejection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/64,65\">",
"     64,65",
"    </a>",
"    ], while autopsy studies of patients with sudden cardiac death have demonstrated a high prevalence of severe cardiac allograft vasculopathy or recent myocardial infarctions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/64,66\">",
"     64,66",
"    </a>",
"    ]. Although ventricular tachyarrhythmias are thought to be the mode of sudden cardiac death, severe bradycardic events may also occur due to advanced atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/67\">",
"     67",
"    </a>",
"    ]. Limited outcome data exists for implantable cardioverter-defibrillator therapy (ICD) in heart transplant recipients. ICD therapy has been reported to effectively terminate ventricular arrhythmias in transplanted patients with severe left ventricular dysfunction, severe allograft vasculopathy, or history of cardiac arrest [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23576/abstract/68\">",
"     68",
"    </a>",
"    ]. The effect of ICD therapy on long-term survival and quality of life in this population is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?25/36/26179?source=see_link\">",
"       \"Patient information: Heart transplantation (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;While most arrhythmias after orthotopic heart transplantation are benign, there are several clinical associations with which the physician must be familiar:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early postoperative bradyarrhythmias due to sinus node dysfunction are probably caused by surgical trauma to the sinoatrial node or its blood supply and can be avoided using a bicaval anastomosis technique. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Sinus node dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       Atropine",
"      </a>",
"      is not an effective treatment for bradycardia when vagal innervation is absent, so intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      is suggested in the unlikely event that treatment of bradycardia is needed in the heart transplant patient undergoing intercurrent surgery. (See",
"      <a class=\"local\" href=\"#H28084306\">",
"       'Treatment of sinus bradycardia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sustained atrial flutter and fibrillation are commonly associated with allograft rejection. Thus, the presence of these arrhythmias should prompt a search for acute rejection by endomyocardial biopsy. Empiric steroid therapy should be considered in such patients prior to return of the biopsy results (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Atrial fibrillation or flutter'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/6/14441?source=see_link\">",
"       \"Acute cardiac allograft rejection: Treatment\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Complex ventricular ectopy or atrioventricular block may be caused by either acute rejection or severe cardiac allograft vasculopathy. Affected patients should undergo endomyocardial biopsy followed, if rejection is not present, by coronary angiography to diagnose cardiac allograft vasculopathy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ventricular arrhythmias'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Conduction disturbances'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/9/18585?source=see_link\">",
"       \"Natural history and diagnosis of cardiac allograft vasculopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Insertion of a permanent pacemaker should be considered in patients with significant bradyarrhythmias, either from sinus node dysfunction or high grade AV block, that are associated with decreased cardiac output and occur in the absence of acute rejection. (See",
"      <a class=\"local\" href=\"#H28084306\">",
"       'Treatment of sinus bradycardia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Conduction disturbances'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with frequent and symptomatic supraventricular tachycardia may be treated with radiofrequency catheter ablation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Supraventricular tachycardias'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15304?source=see_link\">",
"       \"Catheter ablation for AV nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/1\">",
"      Calzolari V, Angelini A, Basso C, et al. Histologic findings in the conduction system after cardiac transplantation and correlation with electrocardiographic findings. Am J Cardiol 1999; 84:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/2\">",
"      Knight CS, Tallaj JA, Rayburn BK, et al. Bradycardia and syncope as a presentation of cardiac allograft rejection involving the conducting system. Cardiovasc Pathol 2010; 19:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/3\">",
"      Cannom DS, Rider AK, Stinson EB, Harrison DC. Electrophysiologic studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propranolol. Am J Cardiol 1975; 36:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/4\">",
"      Yusuf S, Theodoropoulos S, Mathias CJ, et al. Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 1987; 75:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/5\">",
"      Ellenbogen KA, Thames MD, DiMarco JP, et al. Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 1990; 81:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/6\">",
"      Burke MN, McGinn AL, Homans DC, et al. Evidence for functional sympathetic reinnervation of left ventricle and coronary arteries after orthotopic cardiac transplantation in humans. Circulation 1995; 91:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/7\">",
"      Squires RW, Leung TC, Cyr NS, et al. Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc 2002; 77:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/8\">",
"      Wilson RF, Johnson TH, Haidet GC, et al. Sympathetic reinnervation of the sinus node and exercise hemodynamics after cardiac transplantation. Circulation 2000; 101:2727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/9\">",
"      Gallego-Page JC, Segovia J, Alonso-Pulp&oacute;n L, et al. Re-innervation after heart transplantation: a multidisciplinary study. J Heart Lung Transplant 2004; 23:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/10\">",
"      Bengel FM, Ueberfuhr P, Ziegler SI, et al. Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 1999; 99:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/11\">",
"      Arrowood JA, Minisi AJ, Goudreau E, et al. Absence of parasympathetic control of heart rate after human orthotopic cardiac transplantation. Circulation 1997; 96:3492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/12\">",
"      Bernardi L, Valenti C, Wdowczyck-Szulc J, et al. Influence of type of surgery on the occurrence of parasympathetic reinnervation after cardiac transplantation. Circulation 1998; 97:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/13\">",
"      Heinz G, Hirschl M, Buxbaum P, et al. Sinus node dysfunction after orthotopic cardiac transplantation: postoperative incidence and long-term implications. Pacing Clin Electrophysiol 1992; 15:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/14\">",
"      Jacquet L, Ziady G, Stein K, et al. Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 1990; 16:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/15\">",
"      Mackintosh AF, Carmichael DJ, Wren C, et al. Sinus node function in first three weeks after cardiac transplantation. Br Heart J 1982; 48:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/16\">",
"      Heinz G, Kratochwill C, Koller-Strametz J, et al. Benign prognosis of early sinus node dysfunction after orthotopic cardiac transplantation. Pacing Clin Electrophysiol 1998; 21:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/17\">",
"      Heinz G, Ohner T, Laufer G, et al. Demographic and perioperative factors associated with initial and prolonged sinus node dysfunction after orthotopic heart transplantation. The impact of ischemic time. Transplantation 1991; 51:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/18\">",
"      DiBiase A, Tse TM, Schnittger I, et al. Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 1991; 67:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/19\">",
"      Woodard DA, Conti JB, Mills RM Jr, et al. Permanent atrial pacing in cardiac transplant patients. Pacing Clin Electrophysiol 1997; 20:2398.",
"     </a>",
"    </li>",
"    <li>",
"     Mason JW, Harrison DC. Electrophysiology and electropharmacology of the transplanted human heart. In: Cardiac Arrhythmias: Electrophysiology, Diagnosis and Management, Narula OS (Ed), Williams &amp; Wilkins, Baltimore 1979. p.66.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/21\">",
"      Miyamoto Y, Curtiss EI, Kormos RL, et al. Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 1990; 82:IV313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/22\">",
"      Dreyfus G, Jebara V, Mihaileanu S, Carpentier AF. Total orthotopic heart transplantation: an alternative to the standard technique. Ann Thorac Surg 1991; 52:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/23\">",
"      Sarsam MA, Campbell CS, Yonan NA, et al. An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg 1993; 8:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/24\">",
"      Aziz TM, Burgess MI, El-Gamel A, et al. Orthotopic cardiac transplantation technique: a survey of current practice. Ann Thorac Surg 1999; 68:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/25\">",
"      Deleuze PH, Benvenuti C, Mazzucotelli JP, et al. Orthotopic cardiac transplantation with direct caval anastomosis: is it the optimal procedure? J Thorac Cardiovasc Surg 1995; 109:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/26\">",
"      el Gamel A, Yonan NA, Grant S, et al. Orthotopic cardiac transplantation: a comparison of standard and bicaval Wythenshawe techniques. J Thorac Cardiovasc Surg 1995; 109:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/27\">",
"      Rothman SA, Jeevanandam V, Combs WG, et al. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation 1996; 94:II278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/28\">",
"      Davies RR, Russo MJ, Morgan JA, et al. Standard versus bicaval techniques for orthotopic heart transplantation: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg 2010; 140:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/29\">",
"      Cantillon DJ, Tarakji KG, Hu T, et al. Long-term outcomes and clinical predictors for pacemaker-requiring bradyarrhythmias after cardiac transplantation: analysis of the UNOS/OPTN cardiac transplant database. Heart Rhythm 2010; 7:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/30\">",
"      Redmond JM, Zehr KJ, Gillinov MA, et al. Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transplant 1993; 12:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/31\">",
"      Ellenbogen KA, Szentpetery S, Katz MR. Reversibility of prolonged chronotropic dysfunction with theophylline following orthotopic cardiac transplantation. Am Heart J 1988; 116:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/32\">",
"      Cook LS, Will KR, Moran J. Treatment of junctional rhythm after heart transplantation with terbutaline. J Heart Transplant 1989; 8:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/33\">",
"      Rothman SA, Jeevanandam V, Seeber CP, et al. Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction. J Heart Lung Transplant 1995; 14:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/34\">",
"      Rothman, SA, Jeevanandam, V, Hsia, H, et al. A comparison of the electrophysiologic effects of aminophylline and terbutaline in heart transplant recipients with sinus node dysfunction (abstract). Circulation 1995; 92(Suppl 1):I.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/35\">",
"      Melton IC, Gilligan DM, Wood MA, Ellenbogen KA. Optimal cardiac pacing after heart transplantation. Pacing Clin Electrophysiol 1999; 22:1510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/36\">",
"      Mariani JA, McDonald MA, Nanthakumar K, et al. Cardiac resynchronization therapy after atrioventricular node ablation for rapid atrial fibrillation in a heart transplant recipient with late allograft dysfunction. J Heart Lung Transplant 2010; 29:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/37\">",
"      Villa AE, de Marchena EJ, Myerburg RJ, Castellanos A. Comparisons of paired orthotopic cardiac transplant donor and recipient electrocardiograms. Am Heart J 1994; 127:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/38\">",
"      Leonelli FM, Pacifico A, Young JB. Frequency and significance of conduction defects early after orthotopic heart transplantation. Am J Cardiol 1994; 73:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/39\">",
"      Koller-Strametz J, Kratochwill C, Grabenw&ouml;ger M, et al. PR interval adaptation in the denervated transplanted heart. Pacing Clin Electrophysiol 1997; 20:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/40\">",
"      Heinz G, Kratochwill C, Hirschl M, et al. Normal AV node function in patients with sinus node dysfunction after cardiac transplantation. J Card Surg 1993; 8:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/41\">",
"      Markewitz A, Schmoeckel M, Nollert G, et al. Long-term results of pacemaker therapy after orthotopic heart transplantation. J Card Surg 1993; 8:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/42\">",
"      Rubin, S, Hsia, H, Mather, P, et al. Etiology and prognostic implications of post-transplant conduction system disease (abstract). J Heart Lung Transplant 1996; 15:S60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/43\">",
"      Little RE, Kay GN, Epstein AE, et al. Arrhythmias after orthotopic cardiac transplantation. Prevalence and determinants during initial hospitalization and late follow-up. Circulation 1989; 80:III140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/44\">",
"      Scott CD, Dark JH, McComb JM. Arrhythmias after cardiac transplantation. Am J Cardiol 1992; 70:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/45\">",
"      Romhilt DW, Doyle M, Sagar KB, et al. Prevalence and significance of arrhythmias in long-term survivors of cardiac transplantation. Circulation 1982; 66:I219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/46\">",
"      Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/47\">",
"      Pavri BB, O'Nunain SS, Newell JB, et al. Prevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantation. J Am Coll Cardiol 1995; 25:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/48\">",
"      Ahmari SA, Bunch TJ, Chandra A, et al. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant 2006; 25:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/49\">",
"      Macdonald P, Hackworthy R, Keogh A, et al. Atrial overdrive pacing for reversion of atrial flutter after heart transplantation. J Heart Lung Transplant 1991; 10:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/50\">",
"      Cohn WE, Gregoric ID, Radovancevic B, et al. Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg 2008; 85:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/51\">",
"      Dasari TW, Pavlovic-Surjancev B, Patel N, et al. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation. Am J Cardiol 2010; 106:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/52\">",
"      Arenal A, Almendral J, Mu&ntilde;oz R, et al. Mechanism and location of atrial flutter in transplanted hearts: observations during transient entrainment from distant sites. J Am Coll Cardiol 1997; 30:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/53\">",
"      Pinski SL, Bredikis AJ, Winkel E, Trohman RG. Radiofrequency catheter ablation of atrial flutter after orthotopic heart transplantation: insights into the redefined critical isthmus. J Heart Lung Transplant 1999; 18:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/54\">",
"      Marine JE, Schuger CD, Bogun F, et al. Mechanism of atrial flutter occurring late after orthotopic heart transplantation with atrio-atrial anastomosis. Pacing Clin Electrophysiol 2005; 28:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/55\">",
"      Li YG, Gr&ouml;nefeld G, Israel C, et al. Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation. Chin Med J (Engl) 2006; 119:2036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/56\">",
"      Goy JJ, Kappenberger L, Turina M. Wolff-Parkinson-White syndrome after transplantation of the heart. Br Heart J 1989; 61:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/57\">",
"      Gallay P, Albat B, Thevenet A, Grolleau R. Direct current catheter ablation of an accessory pathway in a recipient with refractory reciprocal tachycardia. J Heart Lung Transplant 1992; 11:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/58\">",
"      Neuzner J, Friedl A, Pitschner HF. Radiofrequency catheter ablation of a concealed accessory atrioventricular pathway after heart transplantation. Pacing Clin Electrophysiol 1994; 17:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/59\">",
"      Thompson E, Steinhaus D, Long N, Borkon AM. Preexcitation syndrome in a donor heart. J Heart Transplant 1989; 8:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/60\">",
"      Rothman SA, Hsia HH, Bove AA, et al. Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation. J Heart Lung Transplant 1994; 13:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/61\">",
"      Ott P, Kelly PA, Mann DE, et al. Tachycardia-induced cardiomyopathy in a cardiac transplant recipient: treatment with radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1995; 6:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/62\">",
"      Park JK, Hsu DT, Hordof AJ, Addonizio LJ. Arrhythmias in pediatric heart transplant recipients: prevalence and association with death, coronary artery disease, and rejection. J Heart Lung Transplant 1993; 12:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/63\">",
"      Alexopoulos D, Yusuf S, Bostock J, et al. Ventricular arrhythmias in long term survivors of orthotopic and heterotopic cardiac transplantation. Br Heart J 1988; 59:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/64\">",
"      Berke DK, Graham AF, Schroeder JS, Harrison DC. Arrhythmias in the denervated transplanted human heart. Circulation 1973; 48:III112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/65\">",
"      de Jonge N, Jambroes G, Lahpor JR, Woolley SR. Ventricular fibrillation during acute rejection after heart transplantation. J Heart Lung Transplant 1992; 11:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/66\">",
"      Uretsky BF, Kormos RL, Zerbe TR, et al. Cardiac events after heart transplantation: incidence and predictive value of coronary arteriography. J Heart Lung Transplant 1992; 11:S45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/67\">",
"      Grinstead WC, Smart FW, Pratt CM, et al. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung Transplant 1991; 10:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23576/abstract/68\">",
"      Tsai VW, Cooper J, Garan H, et al. The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry. Circ Heart Fail 2009; 2:197.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3518 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-29CCF0041E-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23576=[""].join("\n");
var outline_f23_1_23576=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24872074\">",
"      MECHANISMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SINUS RATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SINUS NODE DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28084306\">",
"      Treatment of sinus bradycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONDUCTION DISTURBANCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SUPRAVENTRICULAR ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Atrial premature beats",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Atrial fibrillation or flutter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Supraventricular tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      VENTRICULAR ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Ventricular premature beats and nonsustained ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sustained ventricular arrhythmias and sudden cardiac death",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/6/14441?source=related_link\">",
"      Acute cardiac allograft rejection: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15304?source=related_link\">",
"      Catheter ablation for AV nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/53/15192?source=related_link\">",
"      Electrocardiographic and electrophysiologic features of type I atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27463?source=related_link\">",
"      Indications for permanent cardiac pacing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1849?source=related_link\">",
"      Modes of cardiac pacing: Nomenclature and selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/9/18585?source=related_link\">",
"      Natural history and diagnosis of cardiac allograft vasculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?25/36/26179?source=related_link\">",
"      Patient information: Heart transplantation (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9320?source=related_link\">",
"      Prevalence and evaluation of ventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18201?source=related_link\">",
"      Restoration of sinus rhythm in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10344?source=related_link\">",
"      Right bundle branch block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/25/14742?source=related_link\">",
"      Sinus tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/27/441?source=related_link\">",
"      Supraventricular premature beats",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/42/26278?source=related_link\">",
"      The electrocardiogram in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_1_23577="Dorsal hand anatomy";
var content_f23_1_23577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50552%7EPC%2F52461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50552%7EPC%2F52461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal hand anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of dorsal arteries (red) and nerves (green) to the fingers is shown. Each digit is innervated by four digital nerves; the palmar arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dorsal foot anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 411px; height: 541px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The path of dorsal arteries (red) and nerves (green) to the toes is shown. Each digit is innervated by four digital nerves; the plantar arteries and nerves are not shown in this figure. In order to achieve a complete anesthetic effect, it is necessary to block all four nerves. For a complete block of the great toe, there are additional branches that come up the dorsal aspect of the great toe that can be missed if anesthetic is only injected laterally and medially.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23577=[""].join("\n");
var outline_f23_1_23577=null;
var title_f23_1_23578="Localization-related (partial) epilepsy: Causes and clinical features";
var content_f23_1_23578=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Localization-related (partial) epilepsy: Causes and clinical features",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Selim R Benbadis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Timothy A Pedley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/1/23578/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/1/23578/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/1/23578/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epilepsy is a group of heterogeneous conditions, all of which include recurring seizures as an essential component. An epileptic syndrome is a constellation of symptoms, including seizures, signs, and other findings that tend to occur together and define a phenotype. The International Classification of Epileptic Syndromes and Epilepsies, published in 1989, organizes these into partial and generalized epilepsies as well as into idiopathic versus symptomatic epilepsies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/1\">",
"     1",
"    </a>",
"    ]. Partial epilepsies are also referred to as focal or localization-related epilepsies. A revised terminology was published in 2010, but it has not been widely adopted [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the partial epilepsies are either symptomatic (ie, the cause is known) or cryptogenic, which means there is a presumed focal structural cause that cannot be identified historically or be seen with current imaging techniques. If the patient undergoes epilepsy surgery, the cause is sometimes subsequently defined pathologically. Idiopathic partial epilepsies refer to a group of syndromes that usually present in childhood, are generally benign, and presumably have a genetic origin.",
"   </p>",
"   <p>",
"    The causes, clinical manifestations, and electroencephalographic features of the localization-related epilepsies are reviewed here. The idiopathic focal epilepsies of childhood are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=see_link\">",
"     \"Benign partial epilepsies of childhood\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of partial epilepsy and other epilepsy syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=see_link\">",
"     \"Initial treatment of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"     \"Evaluation and management of drug-resistant epilepsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic localization-related epilepsies are, by definition, the result of a focal brain abnormality, even though this cannot always be identified. These cases represent the typical \"adult-onset\" epilepsy, although these are common in childhood as well. If the cause is found or otherwise known, it is said to be symptomatic epilepsy. If imaging studies are normal, the cause remains unknown, and they are said to be cryptogenic. Mesial temporal sclerosis is the most commonly identified cause of symptomatic partial epilepsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Mesial temporal sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mesial temporal sclerosis (MTS, also called hippocampal sclerosis) is the most common underlying cause of temporal lobe epilepsy (TLE) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/3\">",
"     3",
"    </a>",
"    ]. Pathologic examination reveals neuronal loss in the hippocampus, predominantly involving the hilar region, CA1, CA3, CA4, and dentate gyrus, with relative sparing of the CA2 region. A pathologic grading scheme for MTS has been devised which, in preliminary studies, appears to correlate with underlying risk factors and response to surgical treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/4\">",
"     4",
"    </a>",
"    ]. It is typical for MTS pathology to be bilateral, although one side is usually more predominantly involved [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5\">",
"     5",
"    </a>",
"    ]. Reorganization of neuronal networks in response to cell loss is likely to contribute significantly to epileptogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of MTS is not completely understood. While birth and developmental histories are usually normal, a history of febrile seizures in early childhood is common [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In one series, 54 of 67 patients with TLE had a history of febrile seizures and 33 of 35 had complex febrile seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/7\">",
"     7",
"    </a>",
"    ]. A long duration of febrile seizures, in particular, appears to be associated with the development of TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/9\">",
"     9",
"    </a>",
"    ]. In some patients and families, genetic factors appear to influence both the development of febrile seizures and the later development of TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=see_link\">",
"     \"Febrile seizures\"",
"    </a>",
"    .) Some neuroimaging studies suggest that neurodevelopmental factors may contribute to the development of both febrile seizures and TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/12\">",
"     12",
"    </a>",
"    ]. In the smaller subset of patients with MTS who first present as adults, it is possible that an autoimmune limbic encephalitis may be the underlying pathogenesis in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/13-15\">",
"     13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) findings correlate with pathologic observations, demonstrating hippocampal atrophy and abnormal T2 signal intensity in the hippocampus, best seen on thin (2 mm) coronal slices through the hippocampus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Signal change without atrophy is a relatively nonspecific finding and may be seen in up to 30 percent of normal controls [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/20\">",
"     20",
"    </a>",
"    ]. Bilateral MRI abnormalities are visualized in about 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/21\">",
"     21",
"    </a>",
"    ]. Adult patients without TLE, but with a history of febrile seizures in childhood, are sometimes found to demonstrate similar MRI findings [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=see_link&amp;anchor=H3#H3\">",
"     \"Neuroimaging in the evaluation of seizures and epilepsy\", section on 'Magnetic resonance imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Over 80 percent of cases of TLE associated with MTS manifest before the age of 16, but cases presenting in infancy and up to age 32 years have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. Clinically, MTS appears to be a progressive disorder. Seizures, initially controlled with antiepileptic drugs, can reemerge and become medically intractable in up to 60 to 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5\">",
"     5",
"    </a>",
"    ]. A younger age of onset and a history of febrile seizures were associated with a risk of intractability in one longitudinal series [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/23\">",
"     23",
"    </a>",
"    ]. Longitudinal neuroimaging studies have demonstrated progressive neocortical atrophy in patients with pharmacoresistant TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/24-26\">",
"     24-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between MTS and neuropsychiatric symptoms is somewhat controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,27,28\">",
"     5,27,28",
"    </a>",
"    ]. Associated impairments of memory and cognition are often reported, but these may also result from frequent seizures and medication side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. While more severe abnormalities in cognition have been correlated with more severe and bilateral abnormalities on MRI, this may represent confounding bias, rather than cause and effect [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/14,31,32\">",
"     14,31,32",
"    </a>",
"    ]. Similarly, a cause and effect association between MTS and depression, anxiety, and other psychiatric comorbidities is difficult to elucidate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, accumulating evidence from advanced neuroimaging studies suggest that the neurologic abnormalities in patients with MTS extend beyond the temporal lobe and can involve both gray and white matter structures on the contralateral as well as ipsilateral side as well as the cerebellum [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/34-39\">",
"     34-39",
"    </a>",
"    ]. Some studies have correlated the degree of extrahippocampal abnormalities with neuropsychiatric deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Other symptomatic causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;As neuroimaging improves, underlying pathologies are increasingly identified [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. Known causes of localization-related epilepsy include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/3,8,21,44,45\">",
"     3,8,21,44,45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Central nervous system infections",
"     </li>",
"     <li>",
"      Perinatal injury",
"     </li>",
"     <li>",
"      Cortical dysplasias",
"     </li>",
"     <li>",
"      Neoplasms",
"     </li>",
"     <li>",
"      Vascular malformations",
"     </li>",
"     <li>",
"      Head trauma (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4935?source=see_link\">",
"       \"Post-traumatic seizures and epilepsy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Stroke (cerebral infarction, cerebral hemorrhage) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link&amp;anchor=H21#H21\">",
"       \"Overview of the management of epilepsy in adults\", section on 'Post-stroke seizures'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The neuroanatomic locus of seizure origin and demographic features can vary with the underlying etiology. As examples, cerebrovascular disease and neoplasms generally present in later life, while epilepsy resulting from perinatal injury presents in infancy or early childhood. Epilepsy associated with cortical dysplasias presents at a mean age of 7 years (range &lt;1 to 26 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Post-traumatic epilepsy has a peak incidence in early adulthood and most commonly arises from the frontal and temporal lobes.",
"   </p>",
"   <p>",
"    In approximately 25 percent of patients with localization-related epilepsy, no cause is identified. In the absence of other neurologic abnormalities or a family history, such cases are called cryptogenic. In many patients with normal MRI who undergo epilepsy surgery, focal pathologies such as dysplastic lesions, microgyria, and gliosis are identified [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Genetic syndromes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autosomal dominant nocturnal frontal lobe epilepsy is a genetically heterogeneous syndrome manifesting in childhood or adolescence with clusters of brief nocturnal seizures arising in non-rapid eye movement sleep [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48-54\">",
"       48-54",
"      </a>",
"      ]. Cognition and other neurologic functions are usually normal. The age of seizure onset is variable. The course is usually benign with easily controlled seizures; however, one-third will develop drug resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/55\">",
"       55",
"      </a>",
"      ]. Spontaneous seizure remission does not usually occur. Interictal EEG is often normal.",
"     </li>",
"     <li>",
"      Autosomal dominant partial epilepsy with auditory features, also called familial lateral temporal lobe epilepsy, is a genetically heterogeneous syndrome, associated with frequent, secondarily generalized seizures with prominent auditory hallucinations [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/52,56-67\">",
"       52,56-67",
"      </a>",
"      ]. MRI is usually normal as is the interictal EEG. Seizures are easily controlled in most cases.",
"     </li>",
"     <li>",
"      A number of familial syndromes of mesial temporal lobe epilepsy have been described [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/52,68-70\">",
"       52,68-70",
"      </a>",
"      ]. In general, these are autosomal-dominantly inherited but are otherwise genetically heterogeneous. They are variably associated with antecedent febrile seizures and hippocampal sclerosis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/71-73\">",
"       71-73",
"      </a>",
"      ]. The prognosis also varies between disorders; in general, those with hippocampal sclerosis are more likely to have refractory seizures [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/74,75\">",
"       74,75",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accurate genetic testing is available for patients and families with autosomal dominant nocturnal frontal lobe epilepsy and autosomal dominant partial epilepsy with auditory features [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/76\">",
"     76",
"    </a>",
"    ]. While the mutation detection rate is relatively low, when a causative mutation is identified, the etiology is understood and further testing may be avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/77\">",
"     77",
"    </a>",
"    ]. Further information regarding genetic testing for these disorders is available at",
"    <a class=\"external\" href=\"file://www.genetests.org/\">",
"     file://www.genetests.org",
"    </a>",
"    . Counseling for genetic testing is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=see_link\">",
"     \"Genetic counseling and testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Idiopathic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign partial epilepsies of childhood are idiopathic syndromes without a defined genetic basis. Syndromes include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Benign childhood epilepsy with centrotemporal spikes (BCECTS) or benign rolandic epilepsy",
"     </li>",
"     <li>",
"      Benign occipital epilepsy of childhood",
"     </li>",
"     <li>",
"      Panayiotopoulos syndrome",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=see_link\">",
"     \"Benign partial epilepsies of childhood\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL AND EEG FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Semiologic seizure classification attempts to associate clinical features of the seizures with the neuroanatomic focus of seizure origin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/78-80\">",
"     78-80",
"    </a>",
"    ]. However, localization based on either clinical or electroencephalographic (EEG) features alone is often inaccurate. This may be because seizures arise from a part of the brain that is either clinically silent or inaccessible to scalp EEG recordings. Also, seizure activity often spreads quickly from one brain region to another and obscures the original focus of seizure origin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/81\">",
"     81",
"    </a>",
"    ]. As a result, clinical symptoms and EEG activity may reflect regional brain involvement, but not necessarily the primary neuroanatomic site of origin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/82-85\">",
"     82-85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, it is not always possible to distinguish focal from primary generalized seizures on clinical and historical information alone [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/86\">",
"     86",
"    </a>",
"    ]. A seizure aura suggests a focal onset, ie, a partial seizure. While patients with generalized seizures sometimes report nonspecific symptoms that may suggest a seizure aura, highly specific sensory symptoms, such as olfactory auras, are highly diagnostic of partial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/87\">",
"     87",
"    </a>",
"    ]. In one series, both aura and longer seizure duration suggested partial seizures, while ictal eye blinking and higher seizure frequency suggested primary generalized epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/88\">",
"     88",
"    </a>",
"    ]. No clinical feature was absolute.",
"   </p>",
"   <p>",
"    The interictal EEG may be normal. When abnormal, it shows focal spikes or sharp waves. The ictal EEG (if recorded) usually shows a focal or regional discharge at onset. With a normal interictal EEG, the diagnosis of partial epilepsy is based on clinical symptoms. While EEG is an important diagnostic test in evaluating a patient with possible epilepsy, there are several reasons why EEG alone cannot be used to make or refute a specific diagnosis of epilepsy. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=see_link\">",
"     \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of differences in electroclinical semiology and in management, localization-related epilepsies are usually divided into mesiotemporal and neocortical. The most common localization-related epilepsy in adolescents and adults is temporal lobe epilepsy, while extratemporal or neocortical epilepsy is more common in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/89,90\">",
"     89,90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mesial temporal lobe epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Temporal lobe epilepsy (TLE) is the most common of the localization-related epilepsies. Most cases of TLE can be further localized to the mesial temporal lobe (hippocampus, amygdala, and parahippocampal gyrus).",
"   </p>",
"   <p>",
"    Mesiotemporal (hippocampal) sclerosis (MTS) is the most common underlying cause of mesial TLE (81 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/91\">",
"     91",
"    </a>",
"    ]. CNS infection (eg, encephalitis), head trauma, hamartomas, glial tumors, limbic encephalitis, vascular and congenital malformations, and perinatal injury are other causes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/8,14\">",
"     8,14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Mesial temporal sclerosis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4\">",
"     'Other symptomatic causes'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5031012\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complex partial seizures are the most common manifestation of mesial TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,7\">",
"     5,7",
"    </a>",
"    ]. About one-third of patients have secondarily generalized tonic-clonic seizures in addition to complex partial seizures or as their primary seizure type. Only a few patients with mesial TLE develop status epilepticus. Distinctive characteristics of mesial TLE seizures include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An &ldquo;aura&rdquo; (a simple partial seizure with sensory symptoms) occurs in most patients, often with features that are relatively specific for TLE, including a rising epigastric sensation (often likened to a \"roller coaster\" sensation), and psychic or experiential phenomena, such as deja vu, jamais vu, or fear [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,7,44,92-94\">",
"       5,7,44,92-94",
"      </a>",
"      ]. Auras of taste and smell are less common but are also relatively specific for TLE. Auras can occur in isolation as a simple partial seizure or can precede a complex partial seizure. In either case, patients with mesial TLE usually recall the seizure aura.",
"     </li>",
"     <li>",
"      Complex partial seizures usually manifest with a behavioral arrest and staring and last between 30 and 120 seconds. The patients are generally unaware and unresponsive during this period. Occasionally, such patients present with amnestic attacks, but more detailed questioning or observation of the seizures reveal the presence of olfactory hallucinations, other seizure auras, or ictal automatisms [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/95\">",
"       95",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Automatisms are common, occurring in about 60 percent of complex partial seizures of mesial TLE [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,94,96\">",
"       5,94,96",
"      </a>",
"      ]. These are repetitive, stereotyped, purposeless movements. In TLE, they are typically mild, involving the hands (picking, fidgeting, fumbling) and mouth (chewing, lip smacking).",
"     </li>",
"     <li>",
"      Lateralizing features can occur during as well as after a partial complex or secondary generalized seizure [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/5,92,94,96-98\">",
"       5,92,94,96-98",
"      </a>",
"      ]. Unilateral automatisms are usually ipsilateral to the seizure focus, while dystonic posturing almost invariably occurs on the contralateral side. Head deviation at seizure onset is usually ipsilateral to the seizure; when it occurs later, it is contralateral [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/99,100\">",
"       99,100",
"      </a>",
"      ]. This later head turning also has a more forceful, involuntary appearance and is so-characterized as \"versive.\" Contralateral clonic activity is relatively unusual. Lateralizing findings in the setting of mesial temporal sclerosis should be interpreted with some caution, as many of these patients have bilateral, independent seizure foci.",
"     </li>",
"     <li>",
"      Less commonly observed behaviors associated with a temporal lobe seizure include ictal speech and vocalizations, affective behaviors (laughing, crying or fear), hypermotor behaviors usually associated with frontal lobe seizures, and so-called \"leaving behavior\" (walking or running away) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/101-104\">",
"       101-104",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Postictal confusion usually lasts minutes, but may be complicated by psychosis [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/96,105,106\">",
"       96,105,106",
"      </a>",
"      ]. Postictal hemiparesis can occur contralateral to the seizure focus, and postictal aphasia can occur with a seizure emanating from the dominant hemisphere (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link&amp;anchor=H13#H13\">",
"       \"Evaluation of the first seizure in adults\", section on 'Postictal state'",
"      </a>",
"      .). Nose-wiping, performed by the hand ipsilateral to the focus of seizure onset, is a common postictal event in mesial TLE [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/107,108\">",
"       107,108",
"      </a>",
"      ]. Postictal wandering is not specific to TLE, but is seen more often with temporal compared to extratemporal seizures [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/109\">",
"       109",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     EEG findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interictal EEG, when abnormal, typically shows epileptiform sharp waves over the temporal region. These are typically maximum at anterior or mid temporal electrodes",
"    <span class=\"nowrap\">",
"     (F7/F8,",
"    </span>",
"    <span class=\"nowrap\">",
"     T1/T2,",
"    </span>",
"    <span class=\"nowrap\">",
"     T3/T4)",
"    </span>",
"    (",
"    <a class=\"graphic graphic_waveform graphicRef64773 \" href=\"UTD.htm?26/6/26728\">",
"     waveform 1",
"    </a>",
"    ). With repeated studies or prolonged monitoring, the yield of interictal EEG in mesial TLE is over 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/91\">",
"     91",
"    </a>",
"    ]. Bitemporal independent discharges are observed in 30 to 40 percent of patients with mesial TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/91,97\">",
"     91,97",
"    </a>",
"    ]. Temporal intermittent rhythmic delta activity (TIRDA) is observed in as many as 25 to 40 percent of patients being evaluated for temporal lobe resection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/110,111\">",
"     110,111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ictal EEG shows relatively well-defined rhythmic and evolving discharges with a characteristic buildup, with a usual frequency in the theta range (",
"    <a class=\"graphic graphic_waveform graphicRef53015 \" href=\"UTD.htm?20/25/20889\">",
"     waveform 2",
"    </a>",
"    ). Lateralized postictal slowing is often observed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Neocortical epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;When arising from sites outside the mesial temporal lobe, seizures may be simple partial, complex partial, or secondarily generalized. Symptoms depend on the area of cortex affected [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48,112-115\">",
"     48,112-115",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Neocortical temporal lobe epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures arising from the temporal neocortex are relatively uncommon in relation to mesial temporal lobe seizures and are less well characterized. In addition to the rare familial syndrome autosomal dominant partial epilepsy with auditory features, neocortical TLE is associated with other structural abnormalities occurring in this area, including vascular malformations, neoplasms, and traumatic brain injury (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Other symptomatic causes'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    With the close proximity and extensive reciprocal connections between the hippocampus and temporal neocortex, it is not surprising that the clinical syndromes of mesial TLE and neocortical TLE overlap substantially, such that they cannot reliably be distinguished by their clinical characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. However, auras that include auditory hallucinations or distortions, vertigo, or complex visual hallucinations and do not include epigastric phenomena suggest a focus arising from the temporal neocortex rather than the hippocampus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/7,118\">",
"     7,118",
"    </a>",
"    ]. Automatisms are less common in neocortical than mesial TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/117-121\">",
"     117-121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interictal and ictal EEG features do not reliably distinguish mesial TLE and neocortical TLE, although in the latter, one may see more predominant discharges at lateral or posterior temporal electrodes in the interictal recording [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/7,92,117,121\">",
"     7,92,117,121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Frontal lobe epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Making up 30 percent of patients undergoing epilepsy surgery, frontal lobe epilepsy is second to mesial TLE in prevalence. Causes include trauma, neoplasia, vascular malformations, encephalitis, and cortical dysplasia, as well as genetic and idiopathic syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47,48,122-124\">",
"     47,48,122-124",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Etiologies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Reflecting the large area of the frontal cortex and its diverse functions, frontal lobe epilepsy can manifest in many forms. Seizure manifestations generally reflect the area of cortex involved, which is not necessarily the site of origin of the seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/122\">",
"     122",
"    </a>",
"    ]. As an example, among four patients with supplementary motor area (SMA) seizures undergoing epilepsy surgery, only one had an epileptic focus in the SMA [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/122\">",
"     122",
"    </a>",
"    ]. Seizures arising from the orbitofrontal cortex that secondarily involve the adjacent mesial temporal lobe can be indistinguishable from mesial TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47,123\">",
"     47,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Common characteristics of frontal lobe seizures are short duration (&lt;30 seconds) and predilection for occurrence during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47,48,54,112,125-127\">",
"     47,48,54,112,125-127",
"    </a>",
"    ]. The latter is particularly true for frontal lobe complex partial seizures and supplementary motor seizures. Differentiating nocturnal seizures from parasomnias can be challenging; one study suggests that it is not uncommon for the two to co-exist [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Seizure clusters and status epilepticus (whether partial, complex partial, or generalized) are also more common in frontal lobe epilepsy than with TLE. A postictal state may be brief or absent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of the first seizure in adults\", section on 'Postictal state'",
"    </a>",
"    .) Secondary generalization of frontal lobe seizures was at one time thought to be more common than in mesial TLE, but systematic comparisons suggests that this has a similar incidence in both [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47,112,123\">",
"     47,112,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Frontal lobe seizure types include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complex partial seizures are often characterized by hypermotor behaviors (proximal limbs, tonic) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/127,129\">",
"       127,129",
"      </a>",
"      ]. These can produce bizarre-looking episodes that may be mistaken for psychogenic nonepileptic seizures. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33226?source=see_link&amp;anchor=H14#H14\">",
"       \"Psychogenic nonepileptic seizures\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Other features that suggest complex partial seizures of frontal rather than temporal lobe origin include bicycling automatisms as well as pelvic thrusting and other sexual automatisms [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/125,130\">",
"       125,130",
"      </a>",
"      ]. Tonic posturing and head and eye deviation (version), usually contralateral to the side of the seizure focus, can occur in some patients [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/100\">",
"       100",
"      </a>",
"      ]. Vocalizations are also very common.",
"      <br/>",
"      <br/>",
"      While seizure auras are common in frontal lobe epilepsy, they are less ubiquitous than in mesial TLE, and the sensation is often ill-described and typically does not include epigastric phenomenon [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/131\">",
"       131",
"      </a>",
"      ]. Fear and anxiety occur as seizure auras in both TLE and frontal lobe epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47,112,132,133\">",
"       47,112,132,133",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Consciousness may be more preserved in frontal lobe complex partial seizures compared with TLE [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47\">",
"       47",
"      </a>",
"      ]. Patients often report recall of ictal events even though they are not able to respond, but the accuracy of this reporting is not certain [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/125\">",
"       125",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Focal motor seizures involving the primary motor cortex will produce hemiclonic activity in the contralateral face, arm, or leg [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48\">",
"       48",
"      </a>",
"      ]. Seizures may be quite focal (isolated to one limb or face) or may spread (or march) to adjacent areas (ie, Jacksonian seizure). Hemiclonic activity is more common in complex partial seizures of frontal origin than with those in TLE.",
"     </li>",
"     <li>",
"      Supplementary motor area seizures typically produce stereotyped asymmetric tonic movements [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/42,99,122,134,135\">",
"       42,99,122,134,135",
"      </a>",
"      ]. One example is the \"fencing posture,\" in which the head and eye deviate to the contralateral side, with extension of the contralateral arm and flexion of the ipsilateral arm. The most prominent tonic activity occurs contralateral to the seizure focus. Brief superimposed clonic movements or vocalizations may also occur. Speech arrest may accompany seizures arising from the dominant hemisphere. There may be a somatosensory aura. Despite bilateral tonic movements, consciousness is often preserved unless there is secondary generalization.",
"     </li>",
"     <li>",
"      So-called frontal absence seizures manifest with staring, trance-like states. These seizures originate from the frontopolar or medial frontal regions [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48\">",
"       48",
"      </a>",
"      ]. These seizures are more prolonged than other seizure types, often lasting several minutes, sometimes hours, or even days [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Secondary generalization may occur after any of the above initial ictal manifestations. A minority of patients have secondary generalized seizures that occur without preceding complex partial or motor symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/123\">",
"       123",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both ictal and interictal EEG can be misleading in frontal lobe epilepsy with normal or nonspecific abnormal findings. An initial standard outpatient EEG detects interictal epileptiform abnormalities in 29 to 55 percent of patients (",
"    <a class=\"graphic graphic_waveform graphicRef66248 \" href=\"UTD.htm?22/4/22600\">",
"     waveform 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48\">",
"     48",
"    </a>",
"    ]. The yield of abnormal findings increases with repeated and prolonged monitoring.",
"   </p>",
"   <p>",
"    Ictal EEG patterns can include voltage attenuation, electrodecremental response, rhythmic alpha or theta activity, and spike or spike and wave discharges. Up to one-third of patients do not have a diagnostic ictal EEG during a frontal lobe seizure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/48,134\">",
"     48,134",
"    </a>",
"    ]. Large areas of the frontal lobe are inaccessible to surface EEG or can be obscured by prominent motor activity. The use of transverse montages may be helpful to record seizure activity over the vertex. Another problem is that rapid spread of the seizure can lead to false localization and even lateralization of the seizure focus. In some cases, rapid spread of frontal discharges mimics primary generalized spike-wave complexes. This is referred to as \"secondary bilateral synchrony,\" with interictal epileptiform discharges that appear to be primarily generalized but are actually secondarily generalized focal discharges. Frontal lobe absences are associated with an irregular spike-wave pattern.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Occipital lobe epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less common than other localizations, seizures arise from the occipital cortex in 2 to 8 percent of patients in surgical case series [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/136\">",
"     136",
"    </a>",
"    ]. Tumors, vascular malformations, and developmental abnormalities are the most commonly identified abnormalities on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/137\">",
"     137",
"    </a>",
"    ]. Occipital lobe seizures also occur as a benign partial epilepsy of childhood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=see_link&amp;anchor=H14#H14\">",
"     \"Benign partial epilepsies of childhood\", section on 'Benign occipital epilepsy of childhood'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Visual phenomena occur as a seizure aura in about 80 percent of patients. Phenomena vary from unformed images, such as flashing or steady white or colored lights, to very complex visual hallucinations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42569?source=see_link&amp;anchor=H8#H8\">",
"     \"Approach to the patient with visual hallucinations\", section on 'Seizures'",
"    </a>",
"    .) Visual distortions also can occur, including those of size (macropsia, micropsia), shape (metamorphopsia), and color (dyschromatopsia) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/138\">",
"     138",
"    </a>",
"    ]. The visual aura usually manifests in the contralateral visual field, but may be described as bilateral [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/136\">",
"     136",
"    </a>",
"    ]. Ictal blindness also is described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/139\">",
"     139",
"    </a>",
"    ]. Occipital seizure auras also can include experiential, abdominal, and somatosensory phenomena.",
"   </p>",
"   <p>",
"    Complex partial seizures and secondary generalized motor seizures occur in approximately equal proportion in occipital lobe epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/136\">",
"     136",
"    </a>",
"    ]. In the former, motor automatisms, head deviation, and focal motor seizure activity are often described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/139\">",
"     139",
"    </a>",
"    ]. Postictal blindness in one or both hemifields occurs in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/138\">",
"     138",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In occipital lobe epilepsy, the interictal EEG shows localizing spike focus in 50 to 80 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/136,137,139\">",
"     136,137,139",
"    </a>",
"    ]. The ictal EEG is less often localizing, usually because of rapid seizure spread.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Parietal lobe epilepsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures arising from the parietal lobe are uncommon and poorly characterized. Small case series suggest that such patients do not have a distinguishing clinical syndrome. Lateralized somatosensory auras (tingling and numbness) can occur but are neither specific nor sensitive features; anxiety and experiential phenomena have been described as well [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/131,140,141\">",
"     131,140,141",
"    </a>",
"    ]. Ictal phenomena can include asymmetrical tonic or clonic activity as well as complex partial seizures with automatisms, resembling TLE [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/113,140,141\">",
"     113,140,141",
"    </a>",
"    ]. Todd's paralysis can occur as a postictal phenomenon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of the first seizure in adults\", section on 'Postictal state'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both ictal and interictal EEG are unreliable in localizing seizures of parietal lobe origin [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/113,140\">",
"     113,140",
"    </a>",
"    ]. In surgically treated patients, underlying pathologies have included tumor, vascular malformation, and nonspecific gliosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Hemispheric syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;These syndromes are localization-related and neocortical, but the epileptogenic zone is so widespread as to involve nearly an entire hemisphere [",
"    <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/142\">",
"     142",
"    </a>",
"    ]. In most cases, structural abnormalities are identified on magnetic resonance imaging (MRI). EEG abnormalities include multifocal or widespread discharges lateralized to one hemisphere, along with amplitude asymmetry, lateralized or focal slowing, and background slowing. Hemiparesis, hemianopia, and developmental delay often coexist.",
"   </p>",
"   <p>",
"    These hemispheric syndromes are often difficult to treat. Medications used against partial seizures are preferred. In the most refractory cases, functional hemispherectomy can be very effective. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"     \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Causes include perinatal infarction, Rasmussen's syndrome, Sturge-Weber syndrome, and hemimegalencephaly.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perinatal infarction is probably the most common cause. Most infants have acute symptomatic seizures as the initial presenting symptom. The prognosis is determined by the extent of injury; about one-third of patients develop epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/143\">",
"       143",
"      </a>",
"      ]. Seizure types vary and include partial and secondarily generalized seizures. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=see_link\">",
"       \"Stroke in the newborn\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hemimegalencephaly is an extreme form of unilateral cortical dysgenesis, with hamartoma formation. It is not linked to any stage in brain development and can be an isolated finding or occur as part of tuberous sclerosis, Klippel-Trenaunay, and other neurocutaneous syndromes [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/144,145\">",
"       144,145",
"      </a>",
"      ]. Seizures usually begin within the first six months of life. Secondarily generalized seizures are most common, and infantile spasms and tonic seizures also can occur. The baseline EEG is usually very abnormal, often showing hypsarrhythmia or a burst suppression pattern. The MRI appearance of unilaterally thickened cortex with flattened gyri, asymmetric ventricular size, and displacement of midline structures is usually diagnostic.",
"     </li>",
"     <li>",
"      Rasmussen encephalitis is a rare inflammatory disorder of uncertain, probably immune-mediated, pathogenesis that affects one cerebral hemisphere [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/146-148\">",
"       146-148",
"      </a>",
"      ]. Patients typically present between 14 months and 14 years of age with seizures, progressive hemiparesis, and unilateral cerebral atrophy on magnetic resonance imaging (MRI) [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/149,150\">",
"       149,150",
"      </a>",
"      ]. Seizures are unilateral and intractable, frequently evolving into focal motor status epilepticus (\"epilepsia partialis continua\"). MRI may show mild signal intensity change in the cortex and the white matter. Neuropathology shows inflammation. Immunosuppressive treatments are generally unsuccessful.",
"     </li>",
"     <li>",
"      Sturge-Weber syndrome (encephalo-trigeminal angiomatosis) is a sporadic disorder with leptomeningeal angiomatosis. Seizures begin in the first year of life in 75 percent of individuals, and by year 5 in 95 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/1/23578/abstract/151\">",
"       151",
"      </a>",
"      ]. Patients have facial angioma, cortical atrophy, gyriform calcifications, and contralateral hemiparesis and hemianopia. Secondarily generalized seizures are the most common seizure type. On EEG, in addition to epileptiform discharges and slowing on the side of the angiomatosis, low-amplitude or absent background may be seen. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=see_link\">",
"       \"Sturge-Weber syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1733409\">",
"    <span class=\"h1\">",
"     EVALUATION AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with new onset seizures require electroencephalography (EEG) and neuroimaging (magnetic resonance imaging) to characterize the seizure type and cause. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=see_link\">",
"     \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=see_link&amp;anchor=H3#H3\">",
"     \"Neuroimaging in the evaluation of seizures and epilepsy\", section on 'Magnetic resonance imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The symptoms of focal seizures can be difficult to distinguish from nonepileptic paroxysmal conditions, including movement disorders, migraine, sleep disorders, and psychiatric conditions. Prolonged EEG monitoring can be useful when the diagnosis is uncertain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18074?source=see_link\">",
"     \"Nonepileptic paroxysmal disorders in adolescents and adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15368?source=see_link\">",
"     \"Video and ambulatory EEG monitoring in the diagnosis of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localization-related epilepsy, also known as partial or focal epilepsy, arises as a consequence of focal brain pathology (symptomatic focal epilepsy) or as a part of an idiopathic or genetic syndrome.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mesial temporal or hippocampal sclerosis (MTS) is the most commonly identified etiology of temporal lobe epilepsy (TLE), itself the most common localization of partial epilepsy. Febrile seizures, particularly prolonged and complex febrile seizures, are a risk factor for MTS. TLE associated with MTS typically presents in childhood or early adolescence. While initially responsive to antiepileptic drug treatment in most cases, seizures can become medically intractable. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mesial temporal sclerosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other cases of symptomatic partial epilepsy can result from acquired brain injury, neoplasm, or focal developmental anomalies. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Other symptomatic causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Certain clinical features of the seizure can suggest a specific localization-related epileptic syndrome. Electroencephalography (EEG) findings also help localize the focus of seizure onset. Both, however, have imperfect accuracy in categorizing the seizure origin. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical and EEG features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of neuroimaging and electroencephalography to diagnose and further characterize partial epilepsy is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=see_link\">",
"       \"Neuroimaging in the evaluation of seizures and epilepsy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=see_link\">",
"       \"Electroencephalography (EEG) in the diagnosis of seizures and epilepsy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15368?source=see_link\">",
"       \"Video and ambulatory EEG monitoring in the diagnosis of seizures and epilepsy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The management of partial epilepsy and other epilepsy syndromes are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"       \"Overview of the management of epilepsy in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=see_link\">",
"       \"Initial treatment of epilepsy in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"       \"Evaluation and management of drug-resistant epilepsy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=see_link\">",
"       \"Overview of the treatment of seizures and epileptic syndromes in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/1\">",
"      Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/2\">",
"      Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/3\">",
"      Bl&uuml;mcke I. Neuropathology of focal epilepsies: a critical review. Epilepsy Behav 2009; 15:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/4\">",
"      Stefan H, Hildebrandt M, Kerling F, et al. Clinical prediction of postoperative seizure control: structural, functional findings and disease histories. J Neurol Neurosurg Psychiatry 2009; 80:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/5\">",
"      Sadler RM. The syndrome of mesial temporal lobe epilepsy with hippocampal sclerosis: clinical features and differential diagnosis. Adv Neurol 2006; 97:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/6\">",
"      Heinemann U. Basic mechanisms of partial epilepsies. Curr Opin Neurol 2004; 17:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/7\">",
"      French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol 1993; 34:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/8\">",
"      Harvey AS, Grattan-Smith JD, Desmond PM, et al. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995; 12:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/9\">",
"      Maher J, McLachlan RS. Febrile convulsions. Is seizure duration the most important predictor of temporal lobe epilepsy? Brain 1995; 118 ( Pt 6):1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/10\">",
"      Cendes F. Febrile seizures and mesial temporal sclerosis. Curr Opin Neurol 2004; 17:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/11\">",
"      Yasuda CL, Morita ME, Alessio A, et al. Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology 2010; 74:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/12\">",
"      Voets NL, Bernhardt BC, Kim H, et al. Increased temporolimbic cortical folding complexity in temporal lobe epilepsy. Neurology 2011; 76:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/13\">",
"      Bien CG, Urbach H, Schramm J, et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007; 69:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/14\">",
"      Soeder BM, Gleissner U, Urbach H, et al. Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2009; 80:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/15\">",
"      Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010; 67:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/16\">",
"      Van Paesschen W. Qualitative and quantitative imaging of the hippocampus in mesial temporal lobe epilepsy with hippocampal sclerosis. Neuroimaging Clin N Am 2004; 14:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/17\">",
"      Kuzniecky RI, Bilir E, Gilliam F, et al. Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology 1997; 49:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/18\">",
"      Bonilha L, Halford JJ, Rorden C, et al. Automated MRI analysis for identification of hippocampal atrophy in temporal lobe epilepsy. Epilepsia 2009; 50:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/19\">",
"      Hanamiya M, Korogi Y, Kakeda S, et al. Partial loss of hippocampal striation in medial temporal lobe epilepsy: pilot evaluation with high-spatial-resolution T2-weighted MR imaging at 3.0 T. Radiology 2009; 251:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/20\">",
"      Labate A, Gambardella A, Aguglia U, et al. Temporal lobe abnormalities on brain MRI in healthy volunteers: a prospective case-control study. Neurology 2010; 74:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/21\">",
"      Urbach H. Imaging of the epilepsies. Eur Radiol 2005; 15:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/22\">",
"      Auer T, Barsi P, Bone B, et al. History of simple febrile seizures is associated with hippocampal abnormalities in adults. Epilepsia 2008; 49:1562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/23\">",
"      Aguglia U, Beghi E, Labate A, et al. Age at onset predicts good seizure outcome in sporadic non-lesional and mesial temporal sclerosis based temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2011; 82:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/24\">",
"      Bernhardt BC, Worsley KJ, Kim H, et al. Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology 2009; 72:1747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/25\">",
"      Coan AC, Appenzeller S, Bonilha L, et al. Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology 2009; 73:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/26\">",
"      Bernhardt BC, Bernasconi N, Concha L, Bernasconi A. Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome. Neurology 2010; 74:1776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/27\">",
"      Tracy JI, Lippincott C, Mahmood T, et al. Are depression and cognitive performance related in temporal lobe epilepsy? Epilepsia 2007; 48:2327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/28\">",
"      Tudesco Ide S, Vaz LJ, Mantoan MA, et al. Assessment of working memory in patients with mesial temporal lobe epilepsy associated with unilateral hippocampal sclerosis. Epilepsy Behav 2010; 18:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/29\">",
"      Arzimanoglou A, Laurent A, de Schonen S. Nonidiopathic focal epilepsies: methodological problems for a comprehensive neuropsychological evaluation. Epilepsia 2006; 47 Suppl 2:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/30\">",
"      Haag A, Barth S, Zibelius M, et al. Memory for public events in patients with unilateral temporal lobe epilepsy. Epilepsy Behav 2010; 17:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/31\">",
"      Dabbs K, Jones J, Seidenberg M, Hermann B. Neuroanatomical correlates of cognitive phenotypes in temporal lobe epilepsy. Epilepsy Behav 2009; 15:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/32\">",
"      Busch RM, Frazier T, Chapin JS, et al. Role of cortisol in mood and memory in patients with intractable temporal lobe epilepsy. Neurology 2012; 78:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/33\">",
"      Sanchez-Gistau V, Sugranyes G, Baill&eacute;s E, et al. Is major depressive disorder specifically associated with mesial temporal sclerosis? Epilepsia 2012; 53:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/34\">",
"      Labate A, Cerasa A, Aguglia U, et al. Voxel-based morphometry of sporadic epileptic patients with mesiotemporal sclerosis. Epilepsia 2010; 51:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/35\">",
"      Pail M, Br&aacute;zdil M, Marecek R, Mikl M. An optimized voxel-based morphometric study of gray matter changes in patients with left-sided and right-sided mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE/HS). Epilepsia 2010; 51:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/36\">",
"      Bonilha L, Edwards JC, Kinsman SL, et al. Extrahippocampal gray matter loss and hippocampal deafferentation in patients with temporal lobe epilepsy. Epilepsia 2010; 51:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/37\">",
"      Oyegbile TO, Bayless K, Dabbs K, et al. The nature and extent of cerebellar atrophy in chronic temporal lobe epilepsy. Epilepsia 2011; 52:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/38\">",
"      Dabbs K, Becker T, Jones J, et al. Brain structure and aging in chronic temporal lobe epilepsy. Epilepsia 2012; 53:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/39\">",
"      Bonilha L, Nesland T, Martz GU, et al. Medial temporal lobe epilepsy is associated with neuronal fibre loss and paradoxical increase in structural connectivity of limbic structures. J Neurol Neurosurg Psychiatry 2012; 83:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/40\">",
"      Tuchscherer V, Seidenberg M, Pulsipher D, et al. Extrahippocampal integrity in temporal lobe epilepsy and cognition: thalamus and executive functioning. Epilepsy Behav 2010; 17:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/41\">",
"      Riley JD, Franklin DL, Choi V, et al. Altered white matter integrity in temporal lobe epilepsy: association with cognitive and clinical profiles. Epilepsia 2010; 51:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/42\">",
"      Bergin PS, Fish DR, Shorvon SD, et al. Magnetic resonance imaging in partial epilepsy: additional abnormalities shown with the fluid attenuated inversion recovery (FLAIR) pulse sequence. J Neurol Neurosurg Psychiatry 1995; 58:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/43\">",
"      Vattipally VR, Bronen RA. MR imaging of epilepsy: strategies for successful interpretation. Magn Reson Imaging Clin N Am 2006; 14:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/44\">",
"      Fried I, Spencer DD, Spencer SS. The anatomy of epileptic auras: focal pathology and surgical outcome. J Neurosurg 1995; 83:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/45\">",
"      Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002; 125:1719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/46\">",
"      Sisodiya SM, Fauser S, Cross JH, Thom M. Focal cortical dysplasia type II: biological features and clinical perspectives. Lancet Neurol 2009; 8:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/47\">",
"      Jobst BC, Siegel AM, Thadani VM, et al. Intractable seizures of frontal lobe origin: clinical characteristics, localizing signs, and results of surgery. Epilepsia 2000; 41:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/48\">",
"      Jobst BC, Williamson PD. Frontal lobe seizures. Psychiatr Clin North Am 2005; 28:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/49\">",
"      De Marco EV, Gambardella A, Annesi F, et al. Further evidence of genetic heterogeneity in families with autosomal dominant nocturnal frontal lobe epilepsy. Epilepsy Res 2007; 74:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/50\">",
"      Hayman M, Scheffer IE, Chinvarun Y, et al. Autosomal dominant nocturnal frontal lobe epilepsy: demonstration of focal frontal onset and intrafamilial variation. Neurology 1997; 49:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/51\">",
"      Scheffer IE. Autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2000; 41:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/52\">",
"      Andermann F, Kobayashi E, Andermann E. Genetic focal epilepsies: state of the art and paths to the future. Epilepsia 2005; 46 Suppl 10:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/53\">",
"      Cho YW, Yi SD, Lim JG, et al. Autosomal dominant nocturnal frontal lobe epilepsy and mild memory impairment associated with CHRNB2 mutation I312M in the neuronal nicotinic acetylcholine receptor. Epilepsy Behav 2008; 13:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/54\">",
"      Parrino L, De Paolis F, Milioli G, et al. Distinctive polysomnographic traits in nocturnal frontal lobe epilepsy. Epilepsia 2012; 53:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/55\">",
"      Combi R, Dalpr&agrave; L, Tenchini ML, Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview. J Neurol 2004; 251:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/56\">",
"      Winawer MR, Martinelli Boneschi F, Barker-Cummings C, et al. Four new families with autosomal dominant partial epilepsy with auditory features: clinical description and linkage to chromosome 10q24. Epilepsia 2002; 43:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/57\">",
"      Michelucci R, Passarelli D, Pitzalis S, et al. Autosomal dominant partial epilepsy with auditory features: description of a new family. Epilepsia 2000; 41:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/58\">",
"      Pizzuti A, Flex E, Di Bonaventura C, et al. Epilepsy with auditory features: a LGI1 gene mutation suggests a loss-of-function mechanism. Ann Neurol 2003; 53:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/59\">",
"      Kobayashi E, Santos NF, Torres FR, et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch Neurol 2003; 60:1546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/60\">",
"      Bisulli F, Tinuper P, Scudellaro E, et al. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol 2004; 56:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/61\">",
"      Poza JJ, S&aacute;enz A, Mart&iacute;nez-Gil A, et al. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann Neurol 1999; 45:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/62\">",
"      Tessa C, Michelucci R, Nobile C, et al. Structural anomaly of left lateral temporal lobe in epilepsy due to mutated LGI1. Neurology 2007; 69:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/63\">",
"      Kalachikov S, Evgrafov O, Ross B, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002; 30:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/64\">",
"      Fertig E, Lincoln A, Martinuzzi A, et al. Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features. Neurology 2003; 60:1687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/65\">",
"      Striano P, de Falco A, Diani E, et al. A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy. Arch Neurol 2008; 65:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/66\">",
"      Kawamata J, Ikeda A, Fujita Y, et al. Mutations in LGI1 gene in Japanese families with autosomal dominant lateral temporal lobe epilepsy: the first report from Asian families. Epilepsia 2010; 51:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/67\">",
"      Fanciulli M, Santulli L, Errichiello L, et al. LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. Neurology 2012; 78:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/68\">",
"      Andrade-Valen&ccedil;a LP, Valen&ccedil;a MM, Velasco TR, et al. Mesial temporal lobe epilepsy: clinical and neuropathologic findings of familial and sporadic forms. Epilepsia 2008; 49:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/69\">",
"      Angelicheva D, Tournev I, Guergueltcheva V, et al. Partial epilepsy syndrome in a Gypsy family linked to 5q31.3-q32. Epilepsia 2009; 50:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/70\">",
"      Striano P, Busolin G, Santulli L, et al. Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 2011; 76:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/71\">",
"      Depondt C, Van Paesschen W, Matthijs G, et al. Familial temporal lobe epilepsy with febrile seizures. Neurology 2002; 58:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/72\">",
"      Scheffer IE, Harkin LA, Grinton BE, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007; 130:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/73\">",
"      Hedera P, Blair MA, Andermann E, et al. Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3. Neurology 2007; 68:2107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/74\">",
"      Kobayashi E, D'Agostino MD, Lopes-Cendes I, et al. Hippocampal atrophy and T2-weighted signal changes in familial mesial temporal lobe epilepsy. Neurology 2003; 60:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/75\">",
"      Morita ME, Yasuda CL, Betting LE, et al. MRI and EEG as long-term seizure outcome predictors in familial mesial temporal lobe epilepsy. Neurology 2012; 79:2349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/76\">",
"      Ottman R, Hirose S, Jain S, et al. Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia 2010; 51:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/77\">",
"      Scheffer IE. Genetic testing in epilepsy: what should you be doing? Epilepsy Curr 2011; 11:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/78\">",
"      L&uuml;ders H, Acharya J, Baumgartner C, et al. Semiological seizure classification. Epilepsia 1998; 39:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/79\">",
"      Benbadis SR, Thomas P, Pontone G. A prospective comparison between two seizure classifications. Seizure 2001; 10:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/80\">",
"      Blume WT, L&uuml;ders HO, Mizrahi E, et al. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001; 42:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/81\">",
"      G&ouml;tz-Trabert K, Hauck C, Wagner K, et al. Spread of ictal activity in focal epilepsy. Epilepsia 2008; 49:1594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/82\">",
"      Andermann F. Pseudotemporal vs neocortical temporal epilepsy: things aren't always where they seem to be. Neurology 2003; 61:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/83\">",
"      Lee SK, Yun CH, Oh JB, et al. Intracranial ictal onset zone in nonlesional lateral temporal lobe epilepsy on scalp ictal EEG. Neurology 2003; 61:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/84\">",
"      Widdess-Walsh P, Kotagal P, Jeha L, et al. Multiple auras: clinical significance and pathophysiology. Neurology 2007; 69:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/85\">",
"      R&eacute;mi J, Vollmar C, de Marinis A, et al. Congruence and discrepancy of interictal and ictal EEG with MRI lesions in focal epilepsies. Neurology 2011; 77:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/86\">",
"      Ferrie CD. Idiopathic generalized epilepsies imitating focal epilepsies. Epilepsia 2005; 46 Suppl 9:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/87\">",
"      van Donselaar CA, Geerts AT, Schimsheimer RJ. Usefulness of an aura for classification of a first generalized seizure. Epilepsia 1990; 31:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/88\">",
"      Baykan B, Altindag E, Feddersen B, et al. Does semiology tell us the origin of seizures consisting mainly of an alteration in consciousness? Epilepsia 2011; 52:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/89\">",
"      Duchowny M. Epilepsy surgery in children. Curr Opin Neurol 1995; 8:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/90\">",
"      Cross JH, Jayakar P, Nordli D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006; 47:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/91\">",
"      Williamson PD, French JA, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol 1993; 34:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/92\">",
"      Pf&auml;nder M, Arnold S, Henkel A, et al. Clinical features and EEG findings differentiating mesial from neocortical temporal lobe epilepsy. Epileptic Disord 2002; 4:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/93\">",
"      Henkel A, Noachtar S, Pf&auml;nder M, L&uuml;ders HO. The localizing value of the abdominal aura and its evolution: a study in focal epilepsies. Neurology 2002; 58:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/94\">",
"      Fogarasi A, Tuxhorn I, Janszky J, et al. Age-dependent seizure semiology in temporal lobe epilepsy. Epilepsia 2007; 48:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/95\">",
"      Butler CR, Graham KS, Hodges JR, et al. The syndrome of transient epileptic amnesia. Ann Neurol 2007; 61:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/96\">",
"      Williamson PD, Thadani VM, French JA, et al. Medial temporal lobe epilepsy: videotape analysis of objective clinical seizure characteristics. Epilepsia 1998; 39:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/97\">",
"      Serles W, Pataraia E, Bacher J, et al. Clinical seizure lateralization in mesial temporal lobe epilepsy: differences between patients with unitemporal and bitemporal interictal spikes. Neurology 1998; 50:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/98\">",
"      Walser G, Unterberger I, Dobesberger J, et al. Asymmetric seizure termination in primary and secondary generalized tonic-clonic seizures. Epilepsia 2009; 50:2035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/99\">",
"      Wyllie E, L&uuml;ders H, Morris HH, et al. The lateralizing significance of versive head and eye movements during epileptic seizures. Neurology 1986; 36:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/100\">",
"      R&eacute;mi J, Wagner P, O'Dwyer R, et al. Ictal head turning in frontal and temporal lobe epilepsy. Epilepsia 2011; 52:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/101\">",
"      Jin L, Inoue Y. Spontaneous periictal leaving behavior: a potential lateralizing sign in mesial temporal lobe epilepsy. Epilepsia 2009; 50:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/102\">",
"      Horvath RA, Fogarasi A, Schulz R, et al. Ictal vocalizations occur more often in temporal lobe epilepsy with dominant (left-sided) epileptogenic zone. Epilepsia 2009; 50:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/103\">",
"      Toth V, Fogarasi A, Karadi K, et al. Ictal affective symptoms in temporal lobe epilepsy are related to gender and age. Epilepsia 2010; 51:1126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/104\">",
"      Staack AM, Bilic S, Wendling AS, et al. Hyperkinetic seizures in patients with temporal lobe epilepsy: clinical features and outcome after temporal lobe resection. Epilepsia 2011; 52:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/105\">",
"      Kanemoto K, Takeuchi J, Kawasaki J, Kawai I. Characteristics of temporal lobe epilepsy with mesial temporal sclerosis, with special reference to psychotic episodes. Neurology 1996; 47:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/106\">",
"      Alper K, Kuzniecky R, Carlson C, et al. Postictal psychosis in partial epilepsy: a case-control study. Ann Neurol 2008; 63:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/107\">",
"      Leutmezer F, Serles W, Lehrner J, et al. Postictal nose wiping: a lateralizing sign in temporal lobe complex partial seizures. Neurology 1998; 51:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/108\">",
"      Hirsch LJ, Lain AH, Walczak TS. Postictal nosewiping lateralizes and localizes to the ipsilateral temporal lobe. Epilepsia 1998; 39:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/109\">",
"      Tai P, Poochikian-Sarkissian S, Andrade D, et al. Postictal wandering is common after temporal lobe seizures. Neurology 2010; 74:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/110\">",
"      Di Gennaro G, Quarato PP, Onorati P, et al. Localizing significance of temporal intermittent rhythmic delta activity (TIRDA) in drug-resistant focal epilepsy. Clin Neurophysiol 2003; 114:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/111\">",
"      Geyer JD, Bilir E, Faught RE, et al. Significance of interictal temporal lobe delta activity for localization of the primary epileptogenic region. Neurology 1999; 52:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/112\">",
"      Kotagal P, Arunkumar G, hammel J, Mascha E. Complex partial seizures of frontal lobe onset statistical analysis of ictal semiology. Seizure 2003; 12:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/113\">",
"      Cascino GD, Hulihan JF, Sharbrough FW, Kelly PJ. Parietal lobe lesional epilepsy: electroclinical correlation and operative outcome. Epilepsia 1993; 34:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/114\">",
"      Salanova V, Morris HH 3rd, Van Ness PC, et al. Comparison of scalp electroencephalogram with subdural electrocorticogram recordings and functional mapping in frontal lobe epilepsy. Arch Neurol 1993; 50:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/115\">",
"      Williamson PD, Spencer SS. Clinical and EEG features of complex partial seizures of extratemporal origin. Epilepsia 1986; 27 Suppl 2:S46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/116\">",
"      Pacia SV, Devinsky O, Perrine K, et al. Clinical features of neocortical temporal lobe epilepsy. Ann Neurol 1996; 40:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/117\">",
"      O'Brien TJ, Kilpatrick C, Murrie V, et al. Temporal lobe epilepsy caused by mesial temporal sclerosis and temporal neocortical lesions. A clinical and electroencephalographic study of 46 pathologically proven cases. Brain 1996; 119 ( Pt 6):2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/118\">",
"      Gil-Nagel A, Risinger MW. Ictal semiology in hippocampal versus extrahippocampal temporal lobe epilepsy. Brain 1997; 120 ( Pt 1):183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/119\">",
"      Saygi S, Spencer SS, Scheyer R, et al. Differentiation of temporal lobe ictal behavior associated with hippocampal sclerosis and tumors of temporal lobe. Epilepsia 1994; 35:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/120\">",
"      Foldvary N, Lee N, Thwaites G, et al. Clinical and electrographic manifestations of lesional neocortical temporal lobe epilepsy. Neurology 1997; 49:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/121\">",
"      Duchowny M, Jayakar P, Resnick T, et al. Posterior temporal epilepsy: electroclinical features. Ann Neurol 1994; 35:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/122\">",
"      Ikeda A, Sato T, Ohara S, et al. \"Supplementary motor area (SMA) seizure\" rather than \"SMA epilepsy\" in optimal surgical candidates: a document of subdural mapping. J Neurol Sci 2002; 202:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/123\">",
"      Lee JJ, Lee SK, Lee SY, et al. Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities. Seizure 2008; 17:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/124\">",
"      Braakman HM, Vaessen MJ, Hofman PA, et al. Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature. Epilepsia 2011; 52:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/125\">",
"      Williamson PD, Spencer DD, Spencer SS, et al. Complex partial seizures of frontal lobe origin. Ann Neurol 1985; 18:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/126\">",
"      Williamson PD, Spencer DD, Spencer SS, et al. Complex partial status epilepticus: a depth-electrode study. Ann Neurol 1985; 18:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/127\">",
"      Proserpio P, Cossu M, Francione S, et al. Insular-opercular seizures manifesting with sleep-related paroxysmal motor behaviors: a stereo-EEG study. Epilepsia 2011; 52:1781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/128\">",
"      Bisulli F, Vignatelli L, Naldi I, et al. Increased frequency of arousal parasomnias in families with nocturnal frontal lobe epilepsy: a common mechanism? Epilepsia 2010; 51:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/129\">",
"      Tao Y, Guojun Z, Yuping W, et al. Surgical treatment of patients with drug-resistant hypermotor seizures. Epilepsia 2010; 51:2124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/130\">",
"      Spencer SS, Spencer DD, Williamson PD, Mattson RH. Sexual automatisms in complex partial seizures. Neurology 1983; 33:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/131\">",
"      Palmini A, Gloor P. The localizing value of auras in partial seizures: a prospective and retrospective study. Neurology 1992; 42:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/132\">",
"      Leung H, Schindler K, Clusmann H, et al. Mesial frontal epilepsy and ictal body turning along the horizontal body axis. Arch Neurol 2008; 65:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/133\">",
"      Alkawadri R, Mickey BE, Madden CJ, Van Ness PC. Cingulate gyrus epilepsy: clinical and behavioral aspects, with surgical outcomes. Arch Neurol 2011; 68:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/134\">",
"      Morris HH 3rd, Dinner DS, L&uuml;ders H, et al. Supplementary motor seizures: clinical and electroencephalographic findings. Neurology 1988; 38:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/135\">",
"      King DW, Smith JR. Supplementary sensorimotor area epilepsy in adults. Adv Neurol 1996; 70:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/136\">",
"      Blume WT, Whiting SE, Girvin JP. Epilepsy surgery in the posterior cortex. Ann Neurol 1991; 29:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/137\">",
"      Aykut-Bingol C, Bronen RA, Kim JH, et al. Surgical outcome in occipital lobe epilepsy: implications for pathophysiology. Ann Neurol 1998; 44:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/138\">",
"      Taylor I, Scheffer IE, Berkovic SF. Occipital epilepsies: identification of specific and newly recognized syndromes. Brain 2003; 126:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/139\">",
"      Salanova V, Andermann F, Olivier A, et al. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Surgery of occipital lobe epilepsy. Brain 1992; 115 ( Pt 6):1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/140\">",
"      Williamson PD, Boon PA, Thadani VM, et al. Parietal lobe epilepsy: diagnostic considerations and results of surgery. Ann Neurol 1992; 31:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/141\">",
"      Salanova V, Andermann F, Rasmussen T, et al. Parietal lobe epilepsy. Clinical manifestations and outcome in 82 patients treated surgically between 1929 and 1988. Brain 1995; 118 ( Pt 3):607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/142\">",
"      Gonz&aacute;lez-Mart&iacute;nez JA, Gupta A, Kotagal P, et al. Hemispherectomy for catastrophic epilepsy in infants. Epilepsia 2005; 46:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/143\">",
"      Lee J, Croen LA, Lindan C, et al. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann Neurol 2005; 58:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/144\">",
"      Di Rocco C, Battaglia D, Pietrini D, et al. Hemimegalencephaly: clinical implications and surgical treatment. Childs Nerv Syst 2006; 22:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/145\">",
"      Flores-Sarnat L. Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects. J Child Neurol 2002; 17:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/146\">",
"      Bauer J, Elger CE, Hans VH, et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007; 62:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/147\">",
"      Takahashi Y, Mine J, Kubota Y, et al. A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNFalpha, and Granzyme B in CSF. Epilepsia 2009; 50:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/148\">",
"      Mastrangelo M, Mariani R, Menichella A. Eponym : Rasmussen syndrome. Eur J Pediatr 2010; 169:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/149\">",
"      Granata T, Gobbi G, Spreafico R, et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003; 60:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/150\">",
"      Bien CG, Granata T, Antozzi C, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005; 128:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/1/23578/abstract/151\">",
"      Sujansky E, Conradi S. Sturge-Weber syndrome: age of onset of seizures and glaucoma and the prognosis for affected children. J Child Neurol 1995; 10:49.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2231 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-194.187.108.93-5353394DC6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23578=[""].join("\n");
var outline_f23_1_23578=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Mesial temporal sclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Other symptomatic causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Genetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Idiopathic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL AND EEG FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mesial temporal lobe epilepsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5031012\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - EEG findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Neocortical epilepsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Neocortical temporal lobe epilepsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Frontal lobe epilepsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Occipital lobe epilepsy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Parietal lobe epilepsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Hemispheric syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1733409\">",
"      EVALUATION AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/2231\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2231|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?26/6/26728\" title=\"waveform 1\">",
"      EEG temporal sharp wave",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?20/25/20889\" title=\"waveform 2\">",
"      EEG temporal lobe seizure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?22/4/22600\" title=\"waveform 3\">",
"      EEG frontal sharp waves",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42569?source=related_link\">",
"      Approach to the patient with visual hallucinations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/57/921?source=related_link\">",
"      Benign partial epilepsies of childhood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32425?source=related_link\">",
"      Electroencephalography (EEG) in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=related_link\">",
"      Evaluation and management of drug-resistant epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3226?source=related_link\">",
"      Febrile seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=related_link\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=related_link\">",
"      Initial treatment of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13082?source=related_link\">",
"      Neuroimaging in the evaluation of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/41/18074?source=related_link\">",
"      Nonepileptic paroxysmal disorders in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37386?source=related_link\">",
"      Overview of the treatment of seizures and epileptic syndromes in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/52/4935?source=related_link\">",
"      Post-traumatic seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/28/33226?source=related_link\">",
"      Psychogenic nonepileptic seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27690?source=related_link\">",
"      Stroke in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4727?source=related_link\">",
"      Sturge-Weber syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15368?source=related_link\">",
"      Video and ambulatory EEG monitoring in the diagnosis of seizures and epilepsy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_1_23579="Polyp surveillance after first surveillance colonoscopy";
var content_f23_1_23579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86495&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    United States Multi-Society Task Force on Colorectal Cancer recommendations for polyp surveillance after first surveillance colonoscopy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Baseline colonoscopy",
"       </td>",
"       <td class=\"subtitle1\">",
"        First surveillance",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interval for second surveillance (years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        LRA",
"       </td>",
"       <td>",
"        HRA",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LRA",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No adenoma",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        HRA",
"       </td>",
"       <td>",
"        HRA",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LRA",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No adenoma",
"       </td>",
"       <td>",
"        5*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LRA: low risk adenoma; HRA: high risk adenoma.",
"     <br/>",
"     * If the findings on the second surveillance are negative, there is insufficient evidence to make a recommendation.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143:844. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23579=[""].join("\n");
var outline_f23_1_23579=null;
var title_f23_1_23580="Pretest probability of DVT";
var content_f23_1_23580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F75871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F75871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pretest probability of deep vein thrombosis (Wells score)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Clinical feature",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Active cancer (treatment ongoing or within the previous 6 months or palliative)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paralysis, paresis, or recent plaster immobilization of the lower extremities",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recently bedridden for more than 3 days or major surgery, within 4 weeks",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Localized tenderness along the distribution of the deep venous system",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Entire leg swollen",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calf swelling by more than 3 cm when compared to the asymptomatic leg (measured below tibial tuberosity)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pitting edema (greater in the symptomatic leg)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Collateral superficial veins (nonvaricose)",
"       </td>",
"       <td>",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternative diagnosis as likely or more likely than that of deep venous thrombosis",
"       </td>",
"       <td>",
"        -2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High probability",
"       </td>",
"       <td>",
"        &nbsp;3 or greater",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Moderate probability",
"       </td>",
"       <td>",
"        1 or 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low probability",
"       </td>",
"       <td>",
"        0 or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Modification:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        This",
"clinical model has been modified to take one other clinical feature",
"into account: a previously documented deep vein thrombosis (DVT) is",
"given the score of 1. Using this modified scoring system, DVT is either",
"likely or unlikely, as follows:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        DVT likely",
"       </td>",
"       <td>",
"        2 or greater&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        DVT unlikely",
"       </td>",
"       <td>",
"        1 or less",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Wells, PS, Anderson, DR, Bormanis, J, et al, Lancet 1997; 350:1795 and Wells, PS, Anderson, DR, Rodger, M, et al. N Engl J Med 2003; 349:1227.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23580=[""].join("\n");
var outline_f23_1_23580=null;
var title_f23_1_23581="ICD post CABG from CABG-Patch trial";
var content_f23_1_23581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prophylactic ICD does not improve survival in high risk patients after CABG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 224px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The CABG-Patch trial randomized 900 patients with a low ejection fraction and a positive signal-averaged electrocardiogram to an implantable cardioverter-defibrillator or no defibrillator after coronary artery bypass graft surgery. There was no difference in mortality at a mean follow-up of 32 months.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators, N Engl J Med 1997; 337:1569.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23581=[""].join("\n");
var outline_f23_1_23581=null;
var title_f23_1_23582="Lone star tick";
var content_f23_1_23582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F71086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F71086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    An adult female Amblyomma americanum (lone star tick)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 180px; height: 181px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Champman, AS, Bakken, JS, Folk, SM, et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain Spotted Fever, Ehrlichoioses, and Anaplasmosis-United States: A practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 2006; 55(RR-4):1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_1_23582=[""].join("\n");
var outline_f23_1_23582=null;
var title_f23_1_23583="Contents: Primary care neurology";
var content_f23_1_23583=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care neurology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care neurology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cerebrovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42506\">",
"           Antithrombotic therapy to prevent embolization in atrial fibrillation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/27/40378\">",
"           Carotid endarterectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/11/31930\">",
"           Cerebrovascular complications of sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/17/40216\">",
"           Clinical diagnosis of stroke subtypes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/21/18773\">",
"           Definition of transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/37/36439\">",
"           Differential diagnosis of transient ischemic attack and stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/63/9208\">",
"           Etiology and classification of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/39/38522\">",
"           Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33242\">",
"           Initial assessment and management of acute stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/11/10426\">",
"           Initial evaluation and management of transient ischemic attack and minor stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/59/4026\">",
"           Lacunar infarcts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/47/28410\">",
"           Overview of the evaluation of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/24/9608\">",
"           Pathophysiology of symptoms from carotid atherosclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/8/41098\">",
"           Reperfusion therapy for acute ischemic stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/35/34361\">",
"           Screening for asymptomatic carotid artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/33/32281\">",
"           Secondary prevention for specific causes of ischemic stroke and transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/61/30682\">",
"           Secondary prevention of stroke: Risk factor reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/54/37738\">",
"           Treatment of aneurysmal subarachnoid hemorrhage",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cranial nerve dysfunction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/23/36216\">",
"           Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/27/9655\">",
"           Bell's palsy: Prognosis and treatment in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/46/25320\">",
"           Overview of diplopia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/3/34873\">",
"           Trigeminal neuralgia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dementia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/55/1913\">",
"           Cholinesterase inhibitors in the treatment of dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/55/1914\">",
"           Clinical features and diagnosis of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12249\">",
"           Dementia and delirium in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/41/34455\">",
"           Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/57/37786\">",
"           Etiology, clinical manifestations, and diagnosis of vascular dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/25/28057\">",
"           Evaluation of cognitive impairment and dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/20/12618\">",
"           Frontotemporal dementia: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/25/408\">",
"           Frontotemporal dementia: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/36/15946\">",
"           Parkinson disease dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/25/41369\">",
"           Prevention of dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/34/21031\">",
"           Prognosis and treatment of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/22/36202\">",
"           Risk factors for dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/28/4552\">",
"           Safety and societal issues related to dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/55/10104\">",
"           Treatment and prevention of vascular dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/48/27402\">",
"           Treatment of behavioral symptoms related to dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33865\">",
"           Treatment of dementia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of myelin",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/19/35130\">",
"           Diagnosis of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/44/32458\">",
"           Epidemiology and clinical features of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/7/41082\">",
"           Treatment of relapsing-remitting multiple sclerosis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dizziness; nystagmus; and vertigo",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/43/23223\">",
"           Approach to the patient with dizziness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/19/32057\">",
"           Approach to the patient with vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/13/19673\">",
"           Benign paroxysmal positional vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/61/32729\">",
"           Meniere disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/23/34165\">",
"           Overview of nystagmus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/15/13559\">",
"           Treatment of vertigo",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Epilepsy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/9/25753\">",
"           Evaluation of the first seizure in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/39/40570\">",
"           Overview of the management of epilepsy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43994\">",
"           Pharmacology of antiepileptic drugs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/6/22633\">",
"           Risks associated with epilepsy and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/11/19642\">",
"           Status epilepticus in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Headache",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21194\">",
"           Acute treatment of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/19/31033\">",
"           Evaluation of carotid artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3624\">",
"           Headache syndromes other than migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26698\">",
"           Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lumbar puncture",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/10/17576\">",
"           Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/39/33402\">",
"           Evaluation and management of elevated intracranial pressure in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/22/5481\">",
"           Clinical features and diagnosis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/19/25913\">",
"           Clinical features and diagnosis of narcolepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/46/25320\">",
"           Overview of diplopia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22087\">",
"           Overview of hiccups",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/6/40038\">",
"           Pathogenesis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/16/265\">",
"           Treatment and prognosis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/57/7066\">",
"           Treatment of myasthenia gravis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/62/4071\">",
"           Treatment of narcolepsy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Movement disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18857\">",
"           Motor fluctuations and dyskinesia in Parkinson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/46/10984\">",
"           Overview of tremor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/63/32762\">",
"           Pharmacologic treatment of Parkinson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32554\">",
"           Restless legs syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Muscle disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26694\">",
"           Approach to the patient with muscle weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/32/8712\">",
"           Differential diagnosis of peripheral nerve and muscle disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6856\">",
"           Drug-induced myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/40/23173\">",
"           Glucocorticoid-induced myopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/56/36745\">",
"           Muscle enzymes in the evaluation of neuromuscular diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/24/29060\">",
"           Muscle examination in the evaluation of weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/0/33802\">",
"           Statin myopathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic examination",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/8/31879\">",
"           Approach to the patient with sensory loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/30/38377\">",
"           The detailed neurologic examination in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Peripheral neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18551\">",
"           Clinical manifestations and diagnosis of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/46/8938\">",
"           Diabetic autonomic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/32/8712\">",
"           Differential diagnosis of peripheral nerve and muscle disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/41/12951\">",
"           Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/15/42233\">",
"           Overview of lower extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/12/7369\">",
"           Overview of polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/44/8906\">",
"           Overview of upper extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/60/41928\">",
"           Pathogenesis and prevention of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/43/12986\">",
"           Treatment of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/2/5161\">",
"           Treatment of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-9AA6EF40EA-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f23_1_23583=[""].join("\n");
var outline_f23_1_23583=null;
